US20060075522A1 - Genes and uses for plant improvement - Google Patents

Genes and uses for plant improvement Download PDF

Info

Publication number
US20060075522A1
US20060075522A1 US11/188,298 US18829805A US2006075522A1 US 20060075522 A1 US20060075522 A1 US 20060075522A1 US 18829805 A US18829805 A US 18829805A US 2006075522 A1 US2006075522 A1 US 2006075522A1
Authority
US
United States
Prior art keywords
sense
plants
protein
arabidopsis thaliana
transgenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/188,298
Other languages
English (en)
Inventor
Jaclyn Cleveland
Erin Slaten
Mahmood Sayed
Mark Abad
Balasulojini Karunanandaa
Barry Goldman
Daniel Riggsbee
Bettina Darveaux
Angie Ferguson
Maria McDonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monsanto Technology LLC
Original Assignee
Monsanto Technology LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monsanto Technology LLC filed Critical Monsanto Technology LLC
Priority to US11/188,298 priority Critical patent/US20060075522A1/en
Assigned to MONSANTO TECHNOLOGY LLC reassignment MONSANTO TECHNOLOGY LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: MCDONALD, MARIA, KARUNANANDAA, BALASULOJINI, DARVEAUX, BETTINA, ABAD, MARK SCOTT, FERGUSON, ANGELA, GOLDMAN, BARRY S., RIGGSBEE, DANIEL, CLEVELAND, JACLYN, SLATEN, ERIN, SAYED, MAHMOOD
Publication of US20060075522A1 publication Critical patent/US20060075522A1/en
Priority to US11/982,700 priority patent/US9115368B2/en
Priority to US14/121,854 priority patent/US20150135367A1/en
Priority to US15/731,003 priority patent/US10301643B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8273Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for drought, cold, salt resistance
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0008Oxidoreductases (1.) acting on the aldehyde or oxo group of donors (1.2)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01024Succinate-semialdehyde dehydrogenase (NAD+) (1.2.1.24)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y102/00Oxidoreductases acting on the aldehyde or oxo group of donors (1.2)
    • C12Y102/01Oxidoreductases acting on the aldehyde or oxo group of donors (1.2) with NAD+ or NADP+ as acceptor (1.2.1)
    • C12Y102/01016Succinate-semialdehyde dehydrogenase [NAD(P)+] (1.2.1.16)
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/10Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in agriculture
    • Y02A40/146Genetically Modified [GMO] plants, e.g. transgenic plants

Definitions

  • this invention provides transgenic seeds for crops, wherein the genome of said seed comprises recombinant DNA, the expression of which results in the production of transgenic plants that have improved trait(s).
  • Transgenic plants with improved traits such as improved yield, environmental stress tolerance, pest resistance, herbicide tolerance, modified seed compositions, and the like are desired by both farmers and consumers. Although considerable efforts in plant breeding have provided significant gains in desired traits, the ability to introduce specific DNA into plant genomes provides further opportunities for generation of plants with improved and/or unique traits. The ability to develop transgenic plants with improved traits depends in part on the identification of genes that are useful in recombinant DNA constructs for production of transformed plants with improved properties.
  • This invention provides transgenic seeds, transgenic plants and DNA constructs with trait-improving recombinant DNA from a gene for a protein having an amino acid sequence with at least 90% identity to a consensus amino acid sequence in the group consisting of SEQ ID NO: 270 and its homologs through SEQ ID NO: 538, where the respective homolog proteins have amino acid sequences SEQ ID NO: 539 through SEQ ID NO: 22568, as indicated in Table 17.
  • the recombinant DNA encodes a protein; in other cases, the recombinant DNA suppresses endogenous protein expression.
  • this invention provides transgenic seeds for growing crop plants with improved traits, such crop plants with improved traits and the plant parts including transgenic seed produced by such crop plants.
  • transgenic crop plant grown from the transgenic seed has improved yield, as compared to the yield of a control plant, e.g., a plant without the recombinant DNA that produces the increased yield.
  • Some plants of this invention exhibit increased yield by producing a yield increase under non-stress conditions.
  • Other plants of this invention exhibit increased yield by producing a yield increase under one or more environmental stress conditions including, but not limited to, water deficit stress, cold stress, heat stress, high salinity stress, shade stress, and low nitrogen availability stress.
  • Still other plants of this invention have other improved phenotypes, such as improved plant development, plant morphology, plant physiology or seed composition as compared to a corresponding trait of a control plant.
  • the various aspects of this invention are especially useful for transgenic seed and transgenic plants having improved traits in corn (maize), soybean, cotton, canola (rape), wheat, sunflower, sorghum, alfalfa, barley, millet, rice, tobacco, fruit and vegetable crops, and turfgrass.
  • the invention also comprises recombinant DNA constructs.
  • such recombinant DNA constructs useful for the transgenic seed and transgenic plants of this invention comprise a promoter functional in a plant cell operably linked to a DNA segment for expressing a protein associated with a trait in a model plant or a homologue.
  • the recombinant DNA constructs useful for the transgenic seed and transgenic plants of this invention comprise a promoter functional in a plant cell operably linked to a DNA segment for suppressing the level of an endogenous plant protein which is a homologue to a model-plant protein, the suppression of which is associated with an improved trait. Suppression can be effected by any of a variety of methods known in the art, e.g. post transcriptional suppression by anti-sense, sense, dsRNA and the like or by transcriptional suppression.
  • This invention also provides a method of producing a transgenic crop plant having at least one improved trait, wherein the method comprises providing to a grower of transgenic seeds comprising recombinant DNA for expression or suppression of a trait-improving gene provided herein, and growing transgenic plant from said transgenic seed.
  • Such methods are used to generate transgenic crop plants having at least one improved trait under one or more environmental stress conditions including, but not limited to, water deficit stress, cold stress, heat stress, high salinity stress, shade stress, and low nitrogen availability stress.
  • such methods are used to generate transgenic crop plants having improved plant development, plant morphology, plant physiology or seed component phenotype as compared to a corresponding phenotype of a control plant.
  • Such methods are used to generate transgenic crop plants having increased yield under non-stress condition, or under one or more stress conditions.
  • This invention provides transgenic plant seed having in its genome trait-improving recombinant DNA and transgenic plants grown from such seed which exhibit an improved trait as compared a control plant.
  • the invention provides transgenic plants where the improved trait is one or more of improved drought stress tolerance, improved heat stress tolerance, improved cold stress tolerance, improved high salinity stress tolerance, improved low nitrogen availability stress tolerance, improved shade stress tolerance, improved plant growth and development at the stages of seed imbibition through early vegetative phase, and improved plant growth and development at the stages of leaf development, flower production and seed maturity.
  • Particular transgenic plants grown from transgenic seeds of this invention exhibit increased seed yield.
  • Recombinant DNA constructs used in this invention comprise recombinant DNA disclosed herein which produces mRNA to modulate gene expression imparting improved traits to plants.
  • Gene means all or part of the DNA that encodes a protein or mRNA, e.g., chromosomal DNA, plasmid DNA, cDNA, or synthetic DNA, and includes DNA regions flanking the coding sequences, e.g., introns, 5′UTR, 3′UTR, promoters and other DNA involved in the regulation of expression.
  • Transgenic seed means plant seed having a genome altered by the incorporation of recombinant DNA, e.g., by transformation.
  • Transgenic plant means a plant produced from an original transformation event, or progeny from later generations or crosses of a plant to a transformed plant, so long as the progeny contains the recombinant DNA in its genome.
  • Recombinant DNA means a DNA molecule having a genetically engineered modification introduced through a combination of endogenous and/or exogenous DNA elements in a transcription unit, manipulation via mutagenesis, restriction enzymes, and the like or simply by inserting multiple copies of a native transcription unit.
  • Recombinant DNA may comprise DNA segments obtained from different sources, or DNA segments obtained from the same source, but which have been manipulated to join DNA segments which do not naturally exist in the joined form.
  • Recombinant DNA can exist outside of a cell, e.g., as a PCR fragment or in a plasmid, or can be integrated into a genome such as a plant genome.
  • Trait means a physiological, morphological, biochemical, or physical characteristic of a plant or particular plant material or cell. In some instances the characteristic is visible to the human eye, e.g., seed or plant size, or can be measured by biochemical techniques, e.g., detecting the protein, starch, or oil content of seed or leaves, or by observation of a metabolic or physiological process, e.g., by measuring uptake of carbon dioxide, or by the observation of the expression level of a gene or genes, e.g., by employing Northern analysis, RT-PCR, microarray gene expression assays, or reporter gene expression systems, or by agricultural observations such as stress tolerance, yield, or pathogen tolerance.
  • biochemical techniques e.g., detecting the protein, starch, or oil content of seed or leaves
  • a metabolic or physiological process e.g., by measuring uptake of carbon dioxide, or by the observation of the expression level of a gene or genes, e.g., by employing Northern analysis, RT-PCR, microarray gene
  • Control plant is a plant without trait-improving recombinant DNA.
  • a control plant is used to measure and compare trait improvement in a transgenic plant with such trait-improving recombinant DNA.
  • One suitable control plant is a non-transgenic plant of the parental line that was used to generate a transgenic plant.
  • Another suitable control plant is a transgenic plant that comprises recombinant DNA without the specific trait producing DNA, e.g., simply a marker gene.
  • Another suitable control plant is a negative segregant progeny of hemizygous transgenic plant. In certain demonstrations of trait improvement, e.g., in field conditions, the use of a limited number of control plants can cause a wide variation in the control dataset.
  • a “reference” is used, i.e., a trimmed mean of all data from both transgenic and control plants grown under the same conditions and at the same developmental stage.
  • the trimmed mean is calculated by eliminating a specific percentage, i.e., 20%, of the smallest and largest observation from the data set and then calculating the average of the remaining observation.
  • Trait improvement means a detectable and desirable difference in a characteristic in a transgenic plant relative to a control plant or a reference.
  • the trait improvement is measured quantitatively.
  • the trait improvement can entail at least a 2% desirable difference in an observed trait, at least a 5% desirable difference, at least about a 10% desirable difference, at least about a 20% desirable difference, at least about a 30% desirable difference, at least about a 50% desirable difference, at least about a 70% desirable difference, or at least about a 100% difference, or an even greater desirable difference.
  • the trait improvement is only measured qualitatively. It is known that there are natural variations in a trait.
  • the trait improvement observed entails a change of the normal distribution of the trait in the transgenic plant compared with the trait distribution observed in a control plant or a reference, which is evaluated by statistical methods provided herein.
  • Trait improvement includes, but not limited to, yield increase, including increased yield under non-stress conditions and increased yield under environmental stress conditions. Stress conditions may include, for example, drought, shade, fungal disease, viral disease, bacterial disease, insect infestation, nematode infestation, cold temperature exposure, heat exposure, osmotic stress, reduced nitrogen nutrient availability, reduced phosphorus nutrient availability and high plant density.
  • agronomic traits can affect “yield”, including without limitation, plant height, pod number, pod position on the plant, number of internodes, incidence of pod shatter, grain size, efficiency of nodulation and nitrogen fixation, efficiency of nutrient assimilation, resistance to biotic and abiotic stress, carbon assimilation, plant architecture, resistance to lodging, percent seed germination, seedling vigor, and juvenile traits.
  • Other traits that can affect yield include, efficiency of germination (including germination in stressed conditions), growth rate (including growth rate in stressed conditions), ear number, seed number per ear, seed size, composition of seed (starch, oil, protein) and characteristics of seed fill.
  • transgenic plants that demonstrate desirable phenotypic properties that may or may not confer an increase in overall plant yield. Such properties include improved plant morphology, plant physiology or improved components of the mature seed harvested from the transgenic plant.
  • Yield-limiting environment means a condition under which a plant would have the limitation on yield including environmental stress conditions.
  • Stress condition means a condition unfavorable for a plant, which adversely affects plant metabolism, growth and/or development.
  • a plant under the stress condition typically shows reduced germination rate, retarded growth and development, reduced photosynthesis rate, and eventually leading to reduction in yield.
  • water deficit stress means sub-optimal conditions for water and humidity needed for normal growth of natural plants.
  • Relative water content (RWC) is one physiological measure of plant water deficit. RWC measures the effect of osmotic adjustment in plant water status, when a plant is under stressed conditions. RWC can result from heat, drought, high salinity and induced osmotic stress.
  • Cold stress means exposure of a plant to temperatures below, e.g., at least two or more degrees Celsius below, those temperatures that are normal for a particular species or particular strain of plant.
  • “Sufficient nitrogen growth condition” means a growth condition where the soil or growth medium contains or receives enough amounts of nitrogen nutrient to sustain a healthy plant growth and/or for a plant to reach its typical yield for a particular plant species or a particular strain.
  • “Nitrogen nutrient” means any one or any mix of the nitrate salts commonly used as plant nitrogen fertilizer, including, but not limited to, potassium nitrate, calcium nitrate, sodium nitrate, ammonium nitrate.
  • “Ammonium” means any one or any mix of the ammonium salts commonly used as plant nitrogen fertilizer, e.g., ammonium nitrate, ammonium chloride, ammonium sulfate, etc.
  • Low nitrogen availability stress means a plant growth condition that does not contain sufficient nitrogen nutrient to maintain a healthy plant growth and/or for a plant to reach its typical yield under a sufficient nitrogen growth condition; a useful low nitrogen availability stress is a growth condition with 50% or less of the conventional nitrogen inputs.
  • Shade stress means a limited light availability that triggers the shade avoidance response in plant. Plants are subject to shade stress when localized at lower part of the canopy, or in close proximity of neighboring vegetation. Shade stress is exacerbated when the planting density exceeds the average prevailing density for a particular plant species.
  • the average prevailing densities per acre of a few other examples of crop plants in the USA in the year 2000 were: wheat 1,000,000-1,500,000; rice 650,000-900,000; soybean 150,000-200,000, canola 260,000-350,000, sunflower 17,000-23,000 and cotton 28,000-55,000 plants per acre.
  • “Increased yield” of a transgenic plant of this invention is evidenced and measured in a number of ways, including test weight, seed number per plant, seed weight, seed number per unit area (i.e., seeds, or weight of seeds, per acre), bushels per acre, tons per acre, tons per acre, kilo per hectare.
  • corn yield is measured as production of shelled corn kernels per unit of production area, e.g., in bushels per acre or metric tons per hectare, often reported on a moisture adjusted basis, e.g., at 15.5% moisture.
  • Increased yield is often achieved from improved utilization of key biochemical compounds, such as nitrogen, phosphorous and carbohydrate, or from improved responses to environmental stresses, such as cold, heat, drought, salt, and attack by pests or pathogens.
  • Trait-improving recombinant DNA is used to provide transgenic plants having improved growth and development, and ultimately increased yield, as the result of modified expression of plant growth regulators or modification of cell cycle or photosynthesis pathways.
  • “Expression” means transcription of DNA to produce RNA.
  • the resulting RNA includes mRNA encoding a protein, antisense RNA that is complementary to an mRNA encoding a protein, or an RNA transcript comprising a combination of sense and antisense gene regions, such as for use in RNAi gene suppression.
  • Expression also means production of encoded protein from mRNA.
  • “Promoter” means a region of DNA upstream from the start of transcription and involved in recognition and binding of RNA polymerase and other proteins to initiate transcription.
  • a “plant promoter” is a promoter capable of initiating transcription in plant cells whether or not its origin is a plant cell. Exemplary plant promoters include, but are not limited to, those that are obtained from plants, plant viruses, and bacteria which comprise genes expressed in plant cells such as Agrobacterium or Rhizobium .
  • “Tissue preferred” promoters preferentially regulate expression in certain tissues, such as leaves, roots, or seeds.
  • “Tissue specific” promoters predominately regulate expression only in certain tissues.
  • Cell type specific promoter primarily regulate expression in certain cell types in one or more organs, for example, vascular cells in roots or leaves.
  • “Inducible” and “repressible” promoters regulate expression under environmental influences, under the effect of anaerobic conditions, certain chemicals, or the presence of light. Tissue specific, tissue preferred, cell type specific, and inducible promoters constitute a class of “non-constitutive” promoters. “Constitutive” promoters are promoters which are active under most conditions. “Anti-sense orientation” refers to a DNA sequence that is operably linked to a promoter in an orientation where the anti-sense strand is transcribed. “Operably linked” refers to an association of two or more DNA elements in a single construct so that the function of one is affected by the other. For example, a promoter is operably linked with transcribable DNA when it is capable of affecting the expression of that DNA; that is, the coding DNA is under the transcriptional control of the promoter.
  • Consensus sequence means an artificial, amino acid sequence of conserved parts of the proteins encoded by homologous genes, e.g., as determined by a CLUSTAL W alignment of amino acid sequence of homolog proteins.
  • Homologs means genes that produce functionally similar proteins, e.g., in the same organism or in different organisms.
  • a gene can be related to a homolog gene by descent from a common ancestral DNA.
  • Homologs include genes where the relationship is by speciation, e.g., often called orthologs, or by genetic duplication, e.g., often called paralogs. More specifically, “orthologs” include homologs in different species that evolved from a common ancestral gene by specification. Normally orthologs retain the same function in the course of evolution.
  • Parents include homologs in the same species that have diverged from each other as a consequence of genetic duplication.
  • Percent identity means the extent to which two optimally aligned DNA or protein segments are invariant throughout a window of alignment of components, e.g. nucleotide sequence or amino acid sequence.
  • An “identity fraction” for aligned segments of sequences is the number of identical components which are shared divided by the total number of sequence components in the segment used as a reference over a window of alignment which is the smaller of the sequences.
  • Percent identity (“% identity”) is the identity fraction times 100.
  • “% identity” to a consensus amino acid sequence” is 100 times the identity fraction in a window of alignment of an amino acid sequence of a test protein optimally aligned to consensus amino acid sequence of this invention.
  • Arabidopsis means plants of Arabidopsis thaliana.
  • This invention provides recombinant DNA constructs comprising DNA elements for imparting one or more improved traits to transgenic plant.
  • Such constructs typically comprise a promoter operatively linked to DNA to provide for expression of a protein or RNA for gene suppression in a target plant.
  • Recombinant DNA constructs can also include additional regulatory elements, such as 5′ or 3′ untranslated regions (UTRs) such as polyadenylation sites, introns, and transit or signal peptides.
  • UTRs 5′ or 3′ untranslated regions
  • Such recombinant DNA constructs are assembled using methods known to those of ordinary skill in the art.
  • recombinant DNA constructs comprise sense-oriented, trait-imparting DNA operably linked to a promoter that is functional in a plant to provide for expression of the trait-imparting DNA in the sense orientation such that a desired protein is produced.
  • at least a part of the trait-imparting DNA is in an anti-sense orientation for gene suppression activity.
  • Recombinant DNA constructs especially for expressing proteins are typically prepared with a 3′ UTR that a polyadenylation site and signal.
  • Recombinant DNA constructs can also include a transit peptide for targeting of a gene target to a plant organelle, particularly to a chloroplast, leucoplast or other plastid organelle.
  • chloroplast transit peptides see U.S. Pat. No. 5,188,642 and U.S. Pat. No. 5,728,925, incorporated herein by reference.
  • Table 1 provides a list of genes that can provide trait-imparting DNA for recombinant DNA constructs. DNA from each gene was used in a model plant ( Arabidopsis ) to discover associations with improved traits. The DNA was also used to identify homologs from which a consensus amino acid sequence is defined for characterizing the aspects of the invention where recombinant DNA is incorporated in the transgenic seeds, transgenic plants, DNA constructs and methods of this invention. With reference to Table 1:
  • “species” refers to the organism from which the particular DNA was derived. TABLE 1 Nuc SEQ ID Pep SEQ ID construct_id Gene orientation Species 1 270 14324 CGPG1560 SENSE Arabidopsis thaliana 2 271 17484 CGPG2630 SENSE Arabidopsis thaliana 3 272 19109 CGPG1381 ANTI-SENSE Arabidopsis thaliana 4 273 70423 CGPG3165 SENSE Arabidopsis thaliana 5 274 70424 CGPG3180 SENSE Arabidopsis thaliana 6 275 70480 CGPG3833 SENSE Arabidopsis thaliana 7 276 70509 CGPG2420 SENSE Arabidopsis thaliana 8 277 70647 CGPG4334 SENSE Arabidopsis thaliana 9 278 70675 CGPG4519 SENSE Arabidopsis thaliana 10 279 70829 CGPG518 SENSE Arab
  • Trait-imparting DNA for use in this invention for improved traits in plants is disclosed herein as having a DNA sequence of SEQ ID NO:1 through SEQ ID NO:269 and any of the respective homologs.
  • a subset of the trait-imparting DNA includes fragments with less than the full DNA sequence, e.g., consisting of oligonucleotides of at least about 15 to 20 or more consecutive nucleotides from one of the disclosed sequences.
  • Such oligonucleotides are fragments of the larger molecules having a sequence selected from the group consisting of SEQ ID NO: 1 through SEQ ID NO: 269, and find use, for example as probes and primers for detection of the polynucleotides of the invention or for cloning DNA for use in this invention.
  • Useful DNA includes variants of the disclosed DNA. Such variants include naturally occurring, including homologous DNA from genes of the same or a different species, or non-natural variants, for example DNA synthesized using chemical synthesis methods, or generated using recombinant DNA techniques. Degeneracy of the genetic code provides the possibility to substitute at least one nucleotide of a disclosed DNA without causing the amino acid sequence of the protein produced to be changed. Hence, useful DNA can have any base sequence that has been changed from the sequences provided herein by substitution in accordance with degeneracy of the genetic code.
  • Homologs of the trait-imparting DNA generally demonstrate significant identity with the DNA provided herein.
  • Homologous DNA is substantially identical to a trait-imparting DNA if, when the nucleotide sequences are optimally aligned there is at least about 60% nucleotide identity, or higher, e.g., at least 70% or 80% or 85% or even 90% identity or higher, such as 95% or 98% identity over a comparison window of at least 50 to 100 nucleotides, and up to the entire length of the trait-imparting DNA.
  • Optimal alignment of sequences for aligning a comparison window can be conducted by algorithms including computerized implementations of the algorithms (for example, the Wisconsin Genetics Software Package Release 7.0-10.0, Genetics Computer Group, 575 Science Dr., Madison, Wis.).
  • the reference DNA sequence can represent a full-length coding sequence or a portion.
  • Proteins useful for imparting improved traits are entire proteins or at least a sufficient portion of the entire protein to impart the relevant biological activity of the protein. Proteins useful for generation of transgenic plants having improved traits include the proteins with an amino acid sequence provided herein as SEQ ID NO: 270 through SEQ ID NO: 538, as well as homologs of such proteins.
  • One method to identify homologs of the proteins useful in this invention is by comparison of the amino acid sequence of the trait-imparting protein to amino acid sequences of proteins from the same or different organisms, e.g., manually or by using known homology-based search algorithms such as those commonly known and referred to as BLAST, FASTA, and Smith-Waterman.
  • BLAST homology-based search algorithms
  • FASTA FASTA
  • Smith-Waterman a local sequence alignment program, e.g., BLAST, is used to search a database of sequences to find similar sequences, and the summary Expectation value (E-value) is used to measure the sequence base similarity.
  • a reciprocal BLAST search is used to filter hit sequences with significant E-values for ortholog identification.
  • the reciprocal BLAST entails search of the significant hits against a database of amino acid sequences from the base organism that are similar to the sequence of the query protein.
  • a hit is a likely ortholog, when the reciprocal BLAST's best hit is the query protein itself or a protein encoded by a duplicated gene after speciation.
  • homolog is used herein to described proteins that are assumed to have functional similarity by inference from sequence base similarity.
  • the relationship of homologs with amino acid sequences of SEQ ID NO: 539 through SEQ ID NO: 22568 to the proteins with amino acid sequences of SEQ ID NO: 270 through SEQ ID NO: 538 is found is found in Table 17.
  • aspects of the invention also use DNA encoding functional homolog proteins which differ in one or more amino acids from those of protein encoded by disclosed trait-imparting DNA as the result of one or more of the well-known conservative amino acid substitutions, e.g., valine is a conservative substitute for alanine and threonine is a conservative substitute for serine.
  • conservative amino acid substitutions e.g., valine is a conservative substitute for alanine and threonine is a conservative substitute for serine.
  • Conservative substitutions for an amino acid within the native sequence are selected from other members of a class to which the naturally occurring amino acid belongs.
  • amino acids within these various classes include, but are not limited to: (1) acidic (negatively charged) amino acids such as aspartic acid and glutamic acid; (2) basic (positively charged) amino acids such as arginine, histidine, and lysine; (3) neutral polar amino acids such as glycine, serine, threonine, cysteine, tyrosine, asparagine, and glutamine; and (4) neutral nonpolar (hydrophobic) amino acids such as alanine, leucine, isoleucine, valine, proline, phenylalanine, tryptophan, and methionine.
  • conserveed substitutes for an amino acid within a native amino acid sequence are selected from other members of the group to which the naturally occurring amino acid belongs.
  • a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide-containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulfur-containing side chains is cysteine and methionine.
  • Naturally conservative amino acids substitution groups are: valine-leucine, valine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, aspartic acid-glutamic acid, and asparagine-glutamine.
  • a further aspect of the invention uses DNA encoding proteins that differ in one or more amino acids from those of protein encoded from a described trait-imparting DNA as the result of deletion or insertion of one or more amino acids in a native sequence.
  • Homologs of the proteins encoded by disclosed trait-improving DNA will generally demonstrate significant sequence identity, e.g., at least 50% amino acid sequence identity or higher such as at least 70% identity or at least 80% or at least 90% identity with an amino acid sequence of SEQ ID NO:270 through SEQ ID NO:538.
  • Identity of protein homologs is determined by optimally aligning the amino acid sequence of a putative protein homolog with a defined amino acid sequence of a protein encoded by a disclosed trait-imparting DNA and by calculating the percentage of identical and conservatively substituted amino acids over the window of comparison.
  • the window of comparison for determining identity can be the entire amino acid sequence disclosed herein, e.g., the full sequence of any of SEQ ID NO:270 through SEQ ID NO:538.
  • Genes that are homologs to each other can be grouped into families and included in multiple sequence alignments to allow a consensus sequence to be derived. This analysis enables the derivation of conserved and class- (family) specific residues or motifs that are functionally important. These conserved residues and motifs can be further validated with 3D protein structure if available.
  • a consensus sequence is used to define the full scope of the invention, e.g., to identify proteins with a homolog relationship and the corresponding trait-imparting DNA.
  • this invention contemplates that protein homologs include proteins with an amino acid sequence that has at least 90% identity to such a consensus amino acid sequence.
  • promoters that are active in plant cells have been described in the literature. These include promoters present in plant genomes as well as promoters from other sources, including nopaline synthase (NOS) promoter and octopine synthase (OCS) promoters carried on tumor-inducing plasmids of Agrobacterium tumefaciens , caulimovirus promoters such as the cauliflower mosaic virus or figwort mosaic virus promoters.
  • NOS nopaline synthase
  • OCS octopine synthase
  • caulimovirus promoters such as the cauliflower mosaic virus or figwort mosaic virus promoters.
  • CaMV35S cauliflower mosaic virus
  • promoters are usefully altered to contain multiple “enhancer sequences” to assist in elevating gene expression.
  • expression is generally enhanced.
  • enhancers often are found 5′ to the start of transcription in a promoter that functions in eukaryotic cells, and can also be inserted in the forward or reverse orientation 5′ or 3′ to the coding sequence.
  • 5′ enhancing elements are introns.
  • Particularly useful enhancers are the 5′ introns of the rice actin 1 gene and the rice actin 2 gene.
  • Other enhancers include elements from the CaMV 35S promoter, octopine synthase genes, the maize alcohol dehydrogenase gene, the maize shrunken 1 gene and promoters from non-plant eukaryotes.
  • the promoter element in the DNA construct be capable of causing sufficient expression in water deficit conditions.
  • Such promoters can be identified and isolated from the regulatory region of plant genes that are over expressed in water deficit conditions.
  • Specific water-deficit-inducible promoters for use in this invention are derived from the 5′ regulatory region of genes identified as a heat shock protein 17.5 gene (HSP17.5), an HVA22 gene (HVA22), a Rab17 gene and a cinnamic acid 4-hydroxylase (CA4H) gene (CA4H) of Zea maize .
  • HSP17.5 heat shock protein 17.5 gene
  • HVA22 HVA22
  • Rab17 a cinnamic acid 4-hydroxylase
  • CA4H cinnamic acid 4-hydroxylase
  • promoters for use for seed composition modification include promoters from seed genes such as napin (U.S. Pat. No. 5,420,034), maize L3 oleosin (U.S. Pat. No. 6,433,252), zein Z27 (Russell, et al., (1997) Transgenic Res. 6(2):157-166), globulin 1 (Belanger, et al., (1991) Genetics 129:863-872), glutelin 1 (Russell (1997) supra), and peroxiredoxin antioxidant (Perl) (Stacy, et al., (1996) Plant Mol. Biol. 31(6): 1205-1216).
  • seed genes such as napin (U.S. Pat. No. 5,420,034), maize L3 oleosin (U.S. Pat. No. 6,433,252), zein Z27 (Russell, et al., (1997) Transgenic Res. 6(2):157-166), globulin 1 (Belang
  • Promoters of interest for such uses include those from genes such as SSU (Fischhoff, et al., (1992) Plant Mol. Biol. 20:81-93), aldolase and pyruvate orthophosphate dikinase (PPDK) (Taniguchi, et al., (2000) Plant Cell Physiol. 41(1):42-48).
  • Gene overexpression means expression, e.g., of a gene at a level in its native host that exceeds levels of expression in a non-transgenic host.
  • a recombinant DNA construct provides gene overexpression, e.g., as identified in Table 1.
  • Gene suppression includes any of the well-known methods for suppressing expression, typically indicated by reduced levels of protein.
  • Posttranscriptional gene suppression is mediated by transcription of integrated recombinant DNA to form double-stranded RNA (dsRNA) having homology to a gene targeted for suppression.
  • dsRNA double-stranded RNA
  • This formation of dsRNA most commonly results from transcription of an integrated inverted repeat of an element of a target gene, and is a common feature of gene suppression methods known as anti-sense suppression, co-suppression and RNA interference (RNAi).
  • Transcriptional suppression can be mediated by a transcribed dsRNA having homology to a promoter DNA sequence to effect what is called promoter trans suppression.
  • Transgenic plants transformed using such anti-sense oriented DNA constructs for gene suppression can comprise integrated DNA arranged as an inverted repeats that result from insertion of the DNA construct into plants by Agrobacterium -mediated transformation, as disclosed by Redenbaugh, et al., in “Safety Assessment of Genetically Engineered Flavr Savrm Tomato, CRC Press, Inc. (1992).
  • Inverted repeat insertions can comprises a part or all of the T-DNA construct, e.g., an inverted repeat of a complete transcription unit or an inverted repeat of transcription terminator sequence. Screening for inserted DNA comprising inverted repeat elements can improve the efficiency of identifying transformation events effective for gene silencing whether the transformation construct is a simple anti-sense DNA construct which must be inserted in multiple copies or a complex inverted repeat DNA construct (e.g., an RNAi construct) which can be inserted as a single copy.
  • a simple anti-sense DNA construct which must be inserted in multiple copies
  • a complex inverted repeat DNA construct e.g., an RNAi construct
  • RNAi constructs are also disclosed in EP 0426195 A1 (Goldbach, et al.,—1991) where recombinant DNA constructs for transcription into hairpin dsRNA for providing transgenic plants with resistance to tobacco spotted wilt virus. Double-stranded RNAs were also disclosed in WO 94/01550 (Agrawal, et al.,) where anti-sense RNA was stabilized with a self-complementary 3′ segment.
  • 2003/0175965 A1 (Lowe, et al.,) which discloses gene suppression using and RNAi construct comprising a gene coding sequence preceded by inverted repeats of 5′UTR. See also U.S. Patent Application Publication No. 2002/0048814 A1 (Oeller) where RNAi constructs are transcribed to sense or anti-sense RNA which is stabilized by a poly(T)-poly(A) tail. See also U.S. Patent Application Publication No. 2003/0018993 A1 (Gutterson, et al.,) where sense or anti-sense RNA is stabilized by an inverted repeat of the 3′ untranslated region of the NOS gene. See also U.S. Patent Application Publication No. 2003/0036197 A1 (Glassman, et al.,) where RNA having homology to a target is stabilized by two complementary RNA regions.
  • Gene silencing can also be affected by transcribing RNA from both a sense and an anti-sense oriented DNA, e.g., as disclosed by Shewmaker, et al., in U.S. Pat. No. 5,107,065 where in Example 1 a binary vector was prepared with both sense and anti-sense aroA genes. See also U.S. Pat. No. 6,326,193 where gene targeted DNA is operably linked to opposing promoters.
  • Gene silencing can also be affected by transcribing from contiguous sense and anti-sense DNA.
  • Sijen, et al. The Plant Cell, Vol. 8, 2277-2294 (1996) discloses the use of constructs carrying inverted repeats of a cowpea mosaic virus gene in transgenic plants to mediate virus resistance.
  • Such constructs for posttranscriptional gene suppression in plants by double-stranded RNA are also disclosed in International Publication No. WO 99/53050 (Waterhouse, et al.,), International Publication No. WO 99/49029 (Graham, et al.), U.S. 2004-0029283 A1 (Fillatti), U.S. Pat. No. 6,506,559 (Fire, et al.,).
  • Suppression can also be achieved by insertion mutations created by transposable elements may also prevent gene function.
  • transformations with the T-DNA of Agrobacterium are readily achieved and large numbers of transformants can be rapidly obtained.
  • some species have lines with active transposable elements that are efficiently be used for the generation of large numbers of insertion mutations, while some other species lack such options.
  • Mutant plants produced by Agrobacterium or transposon mutagenesis and having altered expression of a polypeptide of interest are identified using the polynucleotides of this invention. For example, a large population of mutated plants are screened to detect mutated plants having an insertion in the gene encoding the polypeptide of interest.
  • This invention also contemplates that the trait-improving recombinant DNA is used in combination with other recombinant DNA to create plants with a multiple desired traits.
  • the combinations generated include multiple copies of any one or more of the recombinant DNA constructs. These stacked combinations are created by any method, including but not limited to cross breeding of transgenic plants, or multiple genetic transformation.
  • heterologous DNA randomly, i.e., at a non-specific location, in the genome of a target plant line.
  • target heterologous DNA insertion in order to achieve site-specific integration, e.g., to replace an existing gene in the genome, to use an existing promoter in the plant genome, or to insert a recombinant polynucleotide at a predetermined site known to be active for gene expression.
  • site specific recombination systems exist which are known to function implants include cre-10 ⁇ as disclosed in U.S. Pat. No. 4,959,317 and FLP-FRT as disclosed in U.S. Pat. No. 5,527,695, both incorporated herein by reference.
  • Transformation methods of this invention are preferably practiced in tissue culture on media and in a controlled environment.
  • Media means any of the numerous nutrient mixtures that are used to grow cells in vitro, that is, outside of the intact living organism.
  • Recipient cell targets include, but are not limited to, meristem cells, callus, immature embryos and gametic cells such as microspores, pollen, sperm and egg cells. It is contemplated that any cell from which a fertile plant is regenerated is useful as a recipient cell. Callus is initiated from tissue sources including, but not limited to, immature embryos, seedling apical meristems, microspores and the like. Cells capable of proliferating as callus are also recipient cells for genetic transformation.
  • transgenic plants of this invention e.g., various media and recipient target cells, transformation of immature embryos and subsequent regeneration of fertile transgenic plants are disclosed in U.S. Pat. Nos. 6,194,636 and 6,232,526 and U.S. 2004-0216189 A1, which are incorporated herein by reference.
  • Marker genes are used to provide an efficient system for identification of those cells that are stably transformed by receiving and integrating a transgenic DNA construct into their genomes.
  • Preferred marker genes provide selective markers that confer resistance to a selective agent, such as an antibiotic or herbicide. Potentially transformed cells are exposed to the selective agent. In the population of surviving cells are those cells where, generally, the resistance-conferring gene has been integrated and expressed at sufficient levels to permit cell survival. Cells are tested further to confirm stable integration of the exogenous DNA.
  • Useful selective marker genes include those conferring resistance to antibiotics such as kanamycin (nptII), hygromycin B (aph IV) and gentamycin (aac3 and aacC4) or resistance to herbicides such as glufosinate (bar or pat) and glyphosate (EPSPS). Examples of such selectable are illustrated in U.S. Pat. Nos. 5,550,318; 5,633,435; 5,780,708 and 6,118,047, all of which are incorporated herein by reference.
  • Screenable markers which provide an ability to visually identify transformants are also often employed, e.g., a gene expressing a colored or fluorescent protein such as a luciferase or green fluorescent protein (GFP) or a gene expressing a beta-glucuronidase or uidA gene (GUS) for which various chromogenic substrates are known. It is also contemplated that combinations of screenable and selectable markers will be useful for identification of transformed cells. See PCT publication WO 99/61129 which discloses use of a gene fusion between a selectable marker gene and a screenable marker gene, e.g., an NPTII gene and a GFP gene.
  • Plants that survive exposure to the selective agent, or cells that have been scored positive in a screening assay, are cultured in regeneration media and allowed to mature into plants.
  • Developing plantlets are transferred to soil less plant growth mix, and hardened off, e.g., in an environmentally controlled chamber at about 85% relative humidity, 600 ppm CO 2 , and 25-250 microeinsteins m ⁇ 2 s ⁇ 1 of light, prior to transfer to a greenhouse or growth chamber for maturation.
  • Plants are preferably matured either in a growth chamber or greenhouse. Plants are regenerated from about 6 wk to 10 months after a transformant is identified, depending on the initial tissue. During regeneration, cells are grown to plants on solid media at about 19 to 28 degrees C. After regenerating plants have reached the stage of shoot and root development, they are transferred to a greenhouse for further growth and testing. Plants are pollinated using conventional plant breeding methods known to those of skill in the art and seed produced.
  • Progeny are recovered from transformed plants and tested for expression of the exogenous recombinant polynucleotide.
  • useful assays include, for example, “molecular biological” assays, such as Southern and Northern blotting and PCR; “biochemical” assays, such as detecting the presence of RNA, e.g., double stranded RNA, or a protein product, e.g., by immunological means (ELISAs and Western blots) or by enzymatic function; plant part assays, such as leaf or root assays; and also, by analyzing the phenotype of the whole regenerated plant.
  • “molecular biological” assays such as Southern and Northern blotting and PCR
  • biochemical assays, such as detecting the presence of RNA, e.g., double stranded RNA, or a protein product, e.g., by immunological means (ELISAs and Western blots) or by enzymatic function
  • Arabidopsis plants were transformed with a large population of recombinant DNA constructs for expressing a large variety of distinct DNA.
  • Transgenic plants were produced and screened to identify those plants having recombinant DNA constructs expressing trait-imparting DNA.
  • a two-step screening process was employed which comprised two passes of trait characterization to ensure that the trait modification was dependent on expression of the recombinant DNA, but not due to the chromosomal location of the integration of the transgene. Twelve independent transgenic lines for each recombinant DNA construct were established and assayed for the transgene expression levels.
  • PCC 6803 pir
  • Avt3p Saccharomyces cerevisiae ] 439 71928 CGPG1617 0 100 gi
  • CS PEG CK PP PEG (SEN2) Arabidopsis thaliana ] 440 72903 CGPG5584 0 91 gi
  • PCC 6803 475 73506 CGPG6496 0 96 gi
  • Pseudomonas fluorescens PfO-1 476 74107 CGPG6590 0 95 gi
  • PCC 6803 534 74465 CGPG6692 1.00E ⁇ 119 99 gi
  • Drought is a water deficit condition that imposes osmotic stress on plants. Plants are particularly vulnerable to drought during the flowering stage.
  • the drought condition in the screening process disclosed in Example 1B started from the flowering time and was sustained to the end of harvesting.
  • the drought tolerance-imparting DNA defined for this invention are used in recombinant DNA constructs that improve plant survival rate under drought conditions. Exemplary recombinant DNA which has been identified for conferring such drought tolerance is identified as such in Table 2. Such identified recombinant DNA is useful in generating transgenic plants that are tolerant to the drought condition imposed during flowering time and in other stages of the plant life cycle.
  • transgenic plants with trait-improving recombinant DNA grown under such sustained drought condition also have increased total seed weight per plant in addition to the increased survival rate within a transgenic population, providing a higher yield potential as compared to control plants.
  • PEG-Improvement of drought tolerance identified by PEG induced osmotic stress tolerance screen Various drought levels can be artificially induced by using various concentrations of polyethylene glycol (PEG) to produce different osmotic potentials (Pilon-Smits et al., (1995) Plant Physiol. 107:125-130).
  • PEG polyethylene glycol
  • a PEG-induced osmotic stress tolerance screen is a useful surrogate for drought tolerance screen. Certain embodiments of transgenic plants with trait-improving recombinant DNA identified in the PEG-induced osmotic stress tolerance screen survive drought conditions providing a higher yield potential as compared to control plants.
  • SS-Improvement of drought tolerance identified by high salinity stress tolerance screen Three different factors are responsible for salt damages: (1) osmotic effects, (2) disturbances in the mineralization process, (3) toxic effects caused by the salt ions, e.g., inactivation of enzymes. While the first factor of salt stress results in the wilting of the plants that is similar to drought effect, the ionic aspect of salt stress is clearly distinct from drought. Exemplary recombinant DNA which has been identified to help plants maintain biomass, root growth and/or plant development in high salinity conditions are identified as such in Table 2.
  • embodiments of trait-improving recombinant DNA identified in a high salinity stress tolerance screen also provide transgenic crops with improved drought tolerance.
  • Embodiments of transgenic plants with trait-improving recombinant DNA identified in a high salinity stress tolerance screen survive drought conditions and/or high salinity conditions providing a higher yield potential as compared to control plants.
  • HS-Improvement of drought tolerance identified by heat stress tolerance screen Heat and drought stress often occur simultaneously, limiting plant growth. Heat stress can cause the reduction in photosynthesis rate, inhibition of leaf growth and osmotic potential in plants. Thus, genes identified as heat stress tolerance conferring genes may also impart improved drought tolerance to plants. As demonstrated from the model plant screen, embodiments of transgenic plants with trait-improving recombinant DNA identified in a heat stress tolerance screen can survive better heat stress conditions and/or drought conditions providing a higher yield potential as compared to control plants.
  • CK and CS-Improvement of tolerance to cold stress Low temperature may immediately result in mechanical constraints, changes in activities of macromolecules, and reduced osmotic potential.
  • Two screening conditions i.e., cold shock tolerance screen (CK) and cold germination tolerance screen (CS), were set up to look for transgenic plants that display visual growth advantage at lower temperature.
  • cold germination tolerance screen the transgenic Arabidopsis plants were exposed to a constant temperature of 8 degrees C. from planting until day 28 post planting. The trait-improving recombinant DNA identified by such screen are particular useful for the production of transgenic plant that can germinate more robustly in a cold temperature as compared to the wild type plants.
  • transgenic plants were first grown under the normal growth temperature of 22 degrees C. until day 8 post planting, and subsequently were placed under 8 degrees C. until day 28 post planting.
  • Embodiments of transgenic plants with trait-improving recombinant DNA identified in a cold shock stress tolerance screen and/or a cold germination stress tolerance screen survive cold conditions providing a higher yield potential as compared to control plants.
  • Certain DNA is identified as useful to produce transgenic plants that have advantages in one or more processes including, but not limited to, germination, seedling vigor, root growth and root morphology under non-stressed conditions.
  • the transgenic plants starting from a more robust seedling are less susceptible to the fungal and bacterial pathogens that attach germinating seeds and seedling.
  • seedlings with advantage in root growth are more resistant to drought stress due to extensive and deeper root architecture. Therefore, genes conferring the growth advantage in early stages to plants are used to generate transgenic plants that are more resistant to various stress conditions due to improved early plant development.
  • Exemplary recombinant DNA that confers both stress tolerance and growth advantages to plants is identified as such in Table 2, e.g., DNA encoding a protein of SEQ ID NO:444 can improve the plant early growth and development, and impart heat and cold tolerance to plants.
  • Embodiments of transgenic plants with trait-improving recombinant DNA identified in the early plant development screen grow better under non-stress conditions and/or stress conditions providing a higher yield potential as compared to control plants.
  • “Late growth and development” encompasses the stages of leaf development, flower production, and seed maturity.
  • Transgenic plants with late growth and development advantages express DNA that is identified as such in Table 2. Such plants exhibit at least one phenotypic characteristics including, but not limited to, increased rosette radius, increased rosette dry weight, seed dry weight, silique dry weight, and silique length.
  • the rosette radius and rosette dry weight are used as the indexes of photosynthesis capacity, and thereby plant source strength and yield potential of a plant.
  • Seed dry weight, silique dry weight and silique length are used as the indexes for plant sink strength, which are considered as the direct determinants of yield.
  • Embodiments of transgenic plants with trait-improving recombinant DNA identified in the late development screen grow better and/or have improved development during leaf development and seed maturation providing a higher yield potential as compared to control plants.
  • LL-Improvement of tolerance to shade stress identified in a low light screen The effects of light on plant development are especially prominent at the seedling stage. Under normal light conditions with unobstructed direct light, a plant seeding develops according to a characteristic photomorphogenic pattern, in which plants have open and expanded cotyledons and short hypocotyls. Then the plant's energy is devoted to cotyledon and leaf development while longitudinal extension growth is minimized. Under low light condition where light quality and intensity are reduced by shading, obstruction or high population density, a seedling displays a shade-avoidance pattern, in which the seedling displays a reduced cotyledon expansion, and hypocotyls extension is greatly increased.
  • a plant under low light condition increases significantly its stem length at the expanse of leaf, seed or fruit and storage organ development, thereby adversely affecting of yield.
  • Recombinant DNA that enables plants to have an attenuated shade avoidance response so that the source of plant can be contributed to reproductive growth efficiently provides embodiments of those plants with higher yield as compared to the wild type plants.
  • Embodiments of transgenic plants with trait-improving recombinant DNA identified in a shade stress tolerance screen have attenuated shade response under shade conditions providing a higher yield potential as compared to control plants.
  • the transgenic plants generated by this invention are suitable for a higher density planting, thereby resulting increased yield per unit area.
  • the metabolism, growth and development of plants are profoundly affected by their nitrogen supply. Restricted nitrogen supply alters shoot to root ratio, root development, activity of enzymes of primary metabolism and the rate of senescence (death) of older leaves.
  • All field crops have a fundamental dependence on inorganic nitrogenous fertilizer. Since fertilizer is rapidly depleted from most soil types, it must be supplied to growing crops two or three times during the growing season. Enhanced nitrogen use efficiency by plants should enable crops cultivated under low nitrogen availability stress condition resulted from low fertilizer input or poor soil quality.
  • Recombinant DNA that imparts enhanced nitrogen use efficiency in transgenic plants is identified in Table 2.
  • Such plants exhibit one or more desirable traits including, but not limited to, increased seedling weight, increased number of green leaves, increased number of rosette leaves, altered root length and advanced flower bud formation.
  • Such plants can also have altered amino acid or protein compositions, increased yield and/or better seed quality.
  • Embodiments of such transgenic plants are productively cultivated under nitrogen nutrient deficient conditions, i.e., nitrogen-poor soils and low nitrogen fertilizer inputs that cause the growth of wild type plants to cease or to be so diminished as to make the wild type plants practically useless under such conditions.
  • the transgenic plants also are advantageously used to achieve earlier maturing, faster growing, and/or higher yielding crops and/or produce more nutritious foods and animal feedstocks when cultivated using nitrogen non-limiting growth conditions.
  • This invention also provides transgenic plants with stacked engineered traits, e.g., a crop having an improved phenotype resulting from expression of a trait-improving recombinant DNA, in combination with herbicide and/or pest resistance traits.
  • genes of the current invention can be stacked with other traits of agronomic interest, such as a trait providing herbicide resistance, for example a glyphosate resistance trait, or insect resistance, such as using a gene from Bacillus thuringiensis to provide resistance against lepidopteran, coliopteran, homopteran, hemiopteran, and other insects.
  • Herbicides for which resistance is useful in a plant include glyphosate herbicides, phosphinothricin herbicides, oxynil herbicides, imidazolinone herbicides, dinitroaniline herbicides, pyridine herbicides, sulfonylurea herbicides, bialaphos herbicides, sulfonamide herbicides and gluphosinate herbicides.
  • glyphosate herbicides glyphosate herbicides, phosphinothricin herbicides, oxynil herbicides, imidazolinone herbicides, dinitroaniline herbicides, pyridine herbicides, sulfonylurea herbicides, bialaphos herbicides, sulfonamide herbicides and gluphosinate herbicides.
  • this invention provides methods for identifying a homologous gene with a DNA sequence homologous to any of SEQ ID NO:1 through SEQ ID NO:269, or a homologous protein with an amino acid sequence homologous to any of SEQ ID NO:270 through SEQ ID NO:538.
  • this invention provides a consensus amino acid sequence for respective homologs for each of SEQ ID NO:270 through SEQ ID NO:538.
  • this invention also includes linking or associating one or more desired traits, or gene function with a homolog sequence disclosed herein.
  • the trait-improving recombinant DNA and methods of using such trait-improving recombinant DNA for generating transgenic plants with improved traits provided by this invention are not limited to any particular plant species. Indeed, the plants of this invention encompass many species of monocots and dicots and include agriculturally useful plants which are cultivated for purposes of food production or industrial applications, e.g., corn and soybean plants and cotton plants. Recombinant DNA constructs optimized for soybean transformation and recombinant DNA constructs optimized for corn transformation are disclosed in the following examples. Other plants of this invention include canola, wheat, sunflower, sorghum, alfalfa, barley, millet, rice, tobacco, fruit and vegetable crops, and turfgrass.
  • embodiments of this invention include the use of both DNA identified in Table 3 and homologs in recombinant DNA for transgenic crop plants with improved traits.
  • Transgenic crop plants with improved traits are identified from populations of plants grown from transgenic events by screening to segregate the plants of this invention from plants without the improved traits.
  • Preferred screens for transgenic crop plants identify plants with improved responses to stress conditions, e.g., assays using imposed stress conditions to detect improved responses to drought stress, nitrogen deficiency, cold growing conditions, or alternatively, under naturally present stress conditions, for example under field conditions.
  • Biomass measures are made on greenhouse or field grown plants and include such measurements as plant height, stem diameter, root and shoot dry weights, and, for corn plants, ear length and diameter.
  • Trait data on morphological changes is collected by visual observation during the process of plant regeneration as well as in regenerated plants transferred to soil.
  • Such trait data includes characteristics such as normal plants, bushy plants, taller plants, thicker stalks, narrow leaves, striped leaves, knotted phenotype, chlorosis, albino, anthocyanin production, or altered tassels, ears or roots.
  • Other enhanced traits are identified by measurements taken under field conditions, such as days to pollen shed, days to silking, leaf extension rate, chlorophyll content, leaf temperature, stand, seedling vigor, internode length, plant height, leaf number, leaf area, tillering, brace roots, stay green, stalk lodging, root lodging, plant health, barrenness/prolificacy, green snap, and pest resistance.
  • trait characteristics of harvested grain are confirmed, including number of kernels per row on the ear, number of rows of kernels on the ear, kernel abortion, kernel weight, kernel size, kernel density and physical grain quality.
  • hybrid yield in transgenic corn plants expressing trait-imparting DNA of this invention it is useful to test hybrid plants over multiple years at multiple locations in a geographical location where corn is conventionally grown, e.g., in Iowa, Illinois and Kansas, under “normal” field conditions as well as under stress conditions, e.g., under drought or population density stress.
  • Transgenic crop plants are used to provide other aspects of this invention such as transgenic seeds of crop plants. Seeds of transgenic plants are used to propagate more progeny plants which contain the trait-improving recombinant DNA constructs of this invention. These progeny plants are within the scope of this invention when they contain a trait-improving recombinant DNA construct of this invention, whether or not these plants are selfed or crossed with different varieties of plants.
  • Transgenic crop plants having enhanced traits are identified from populations of plants transformed as described herein by evaluating the trait in a variety of assays to detect an enhanced agronomic trait.
  • Useful assays include analyses to detect changes in the chemical composition, biomass, physiological properties and morphology of the plant. Changes in chemical compositions such as nutritional composition of grain are detected by analysis of the seed composition and content of protein, free amino acids, oil, free fatty acids, starch or tocopherols.
  • Changes in biomass characteristics are detected in greenhouse or field grown plants and include plant height, stem diameter, root and shoot dry weights; and, for corn plants, ear length and diameter. Changes in physiological properties are identified by evaluating responses to stress conditions, e.g., assays using imposed stress conditions such as water deficit, nitrogen deficiency, cold growing conditions, pathogen or insect attack or light deficiency, or increased plant density. Changes in morphology are measured by visual observation of tendency of a transformed plant with an enhanced agronomic trait to also appear to be a normal plant as compared to changes toward bushy, taller, thicker, narrower leaves, striped leaves, knotted trait, chlorosis, albino, anthocyanin production, or altered tassels, ears or roots.
  • stress conditions e.g., assays using imposed stress conditions such as water deficit, nitrogen deficiency, cold growing conditions, pathogen or insect attack or light deficiency, or increased plant density. Changes in morphology are measured by visual observation of
  • Other screening properties include days to pollen shed, days to silking, leaf extension rate, chlorophyll content, leaf temperature, stand, seedling vigor, internode length, plant height, leaf number, leaf area, tillering, brace roots, stay green, stalk lodging, root lodging, plant health, barrenness/prolificacy, green snap, and pest resistance.
  • phenotypic characteristics of harvested grain are evaluated, including number of kernels per row on the ear, number of rows of kernels on the ear, kernel abortion, kernel weight, kernel size, kernel density and physical grain quality.
  • Seeds for transgenic crop plants with enhanced agronomic traits of this invention are corn, soybean and cotton seeds, as well as seeds for canola, wheat, sunflower, sorghum, alfalfa, barley, millet, rice, tobacco, fruit and vegetable crops, and turfgrass.
  • transgenic crop plants of this invention exhibit enhanced nitrogen use efficiency as compared to control plants. Higher nitrogen soil applications increase seed protein and starch accumulation, and lead to larger seed weight and larger kernel number per ear. Recent improvements in elite high yielding corn hybrid genotypes include the ability to utilize nitrogen efficiently. DNA causing the enhanced nitrogen use efficiency in crop plants are especially useful, e.g., for improving yield. Enhanced nitrogen use efficiency is assessed by measuring changes in plant growth such as leaf area production, shoot biomass, chlorophyll content in plants grown in nitrogen limiting conditions and/or nitrogen sufficient conditions. It is useful to conduct a first screen in nitrogen limiting conditions and confirm replicate transgenic events in both nitrogen limiting and nitrogen sufficient conditions.
  • Table 4 shows an amount of nutrients in the nutrient solution for nitrogen limiting conditions (low N) and nitrogen sufficient conditions (high N) which are useful for nitrogen use efficiency screening.
  • low N nitrogen limiting conditions
  • high N nitrogen sufficient conditions
  • transgenic plants of this invention exhibit improved yield as compared to a control plant. Improved yield can result from a variety or other traits such as enhanced seed sink potential, e.g., the number and size of endosperm cells or kernels, and/or enhanced sink strength, e.g., the rate of starch biosynthesis. Sink potential is established very early during kernel development, as endosperm cell number and cell size are determined within the first few days after pollination.
  • Effective yield screening of transgenic corn uses hybrid progeny of the transgenic event over multiple locations with plants grown under optimal production management practices, and maximum pest control.
  • a useful target for improved yield is a 5% to 10% increase in yield as compared to yield produced by plants grown from seed for a control plant.
  • Useful screening in multiple and diverse geographic locations e.g., up to 16 or more locations, over one or more planting seasons, e.g., at least two planting seasons, is useful to statistically distinguish yield improvement from natural environmental effects.
  • Useful hybrid screening includes planting multiple transgenic plants, positive and negative control plants, and pollinator plants in standard plots, e.g., 2 row plots, 20 feet long by 5 feet wide with 30 inches distance between rows and a 3 foot alley between ranges.
  • Plants from separate transgenic events can be grouped by recombinant DNA constructs with groups randomly placed in the field.
  • a pollinator plot of a high quality corn line is planted for every two plots to allow open pollination when using male sterile transgenic events.
  • a useful planting density is about 30,000 plants/acre.
  • Surrogate indicators for screening for yield improvement include source capacity (biomass), source output (sucrose and photosynthesis), sink components (kernel size, ear size, starch in the seed), development (light response, height, density tolerance), maturity, early flowering trait and physiological responses to high density planting, e.g., at 45,000 plants per acre.
  • a useful statistical measurement approach comprises three components, i.e., modeling spatial autocorrelation of the test field separately for each location, adjusting traits of recombinant DNA events for spatial dependence for each location, and conducting an across location analysis.
  • a first step in modeling spatial autocorrelation is estimating the covariance parameters of the semivariogram.
  • a spherical covariance model is assumed to model the spatial autocorrelation. Because of the size and nature of the trial, it is likely that the spatial autocorrelation may change. Therefore, anisotropy is also assumed along with spherical covariance structure. The following set of equations describes the statistical form of the anisotropic spherical covariance model.
  • (v, ⁇ 2 , ⁇ , ⁇ n , ⁇ j ), where v is the nugget effect, ⁇ 2 is the partial sill, ⁇ is a rotation in degrees clockwise from north, ⁇ n is a scaling parameter for the minor axis and ⁇ j is a scaling parameter for the major axis of an anisotropical ellipse of equal covariance.
  • the five covariance parameters that define the spatial trend will then be estimated by using data from heavily replicated pollinator plots via restricted maximum likelihood approach. In a multi-location field trial, spatial trend are modeled separately for each location.
  • a variance-covariance structure is generated for the data set to be analyzed.
  • This variance-covariance structure contains spatial information required to adjust yield data for spatial dependence.
  • a nested model that best represents the treatment and experimental design of the study is used along with the variance-covariance structure to adjust the yield data.
  • the nursery or the seed batch effects can also be modeled and estimated to adjust the yields for any yield parity caused by seed batch differences.
  • transgenic crop plants of this invention exhibit improved yield resulting from improved water use efficiency and/or drought tolerance.
  • a greenhouse screen for transgenic corn plants for water use efficiency measures changes in plant growth rate, e.g., at least a 10% improvement, in height and biomass during a vegetative drought treatment, as compared to control plants.
  • the hydration status of the shoot tissues following the drought is also measured.
  • Plant Initial Height (SIH) is plant height after 3 weeks of growth under optimum conditions.
  • Sp Wilt Height (SWH) is plant height at the end of a 6 day drought.
  • Time course experiments have shown that at about 3 days of drought, wild type plants basically stop growing and begin to wilt.
  • a transgenic plant with improved water use efficiency will continue to grow (probably to a lesser extent than with water) and thereby end up as a significantly taller plant at the end of a drought experiment.
  • SWM Shoot Wilt Mass
  • SDM is measure after 2 to 3 weeks in a drying chamber.
  • STM Shoot Turgid mass
  • STM-SWM is indicative of water use efficiency in plants where recovery from stress is more important than stress tolerance per se.
  • Relative water content (RWC) is a measurement of how much (%) of the plant is water at harvest.
  • RWC (SWM ⁇ SDM)/(STM ⁇ SDM)*100. Fully watered corn plants are about 98% RWC. Typically, in a wilt screen the plants are about 60% RWC. Plants with higher RWC at the end of a drought are considered to be healthier plants and more fit for post-drought recovery and growth.
  • RGR Relative Growth Rate
  • transgenic crop plants of this invention exhibit improved growth under cold stress, e.g., in a cold germination assay, in a cold shock assay, in an early seedling growth assay and in root-shoot biomass assay.
  • transgenic seeds from transgenic plants e.g., R2 inbred seeds or F1 hybrid seeds
  • seeds of two types of control plants e.g., negative segregants from the transgenic event or wild type, non-transgenic seeds of the transformed genotype
  • a useful fungicide such as Captan fungicide (available from Arvesta Corp as MAESTRO® 80DF Fungicide) is applied at the rate of 0.43 mL Captan per 45 g of corn seeds which are dried to provide fungicide-coated seeds.
  • a useful cold screen for transgenic corn seeds ten seeds per transgenic event are placed on filter paper (e.g., Whatman No. 1) in the lid of a Petri dish with 5 ml of water. A closed Petri dish is placed in a growth chamber set at 11 degrees C. for inbred corn seed or 9.5 degrees C. for hybrid corn seed. 2 ml of water is added on day 3 and day 10. Seeds are considered germinated if the emerged radicle size is 1 cm. Cold seeds are scored every 2 days from day 10 up to day 30. Tissue samples are collected at random on the last day of the experiment for confirmation of RNA expression.
  • filter paper e.g., Whatman No.
  • a cold shock assay seeds are planted in potting media and placed in a growth chamber set at 23 degrees C., relative humidity of 65% with 12 hour day and night photoperiod (300 uE/m2-min). Planted seeds are watered for 20 minute every other day by sub-irrigation and flats are rotated every third day. On day 10 after planting the transgenic positive and wild type control plants are positioned in flats in an alternating pattern. Chlorophyll fluorescence of plants is measured on the tenth day during the dark period of growth by using a Walz PAM-2000 portable fluorometer following manufacturer's instructions. After chlorophyll measurements, leaf samples from each event are collected for confirming the expression of recombinant DNA. The plants are then exposed to temperatures of 5 degrees C.
  • V3 leaf damage is determined visually by estimating percent of green V2 leaf. Statistical differences in V3 leaf growth, V2 leaf necrosis and fluorescence during pre-shock and cold shock can be used for estimation of cold shock damage on corn plants.
  • the first set is a group of transgenic seeds from transgenic plants; the second set is negative segregants of the transgenic seed; and the third seed set is seed from two cold tolerant and two cold sensitive wild-type controls. All seeds are treated with a fungicide as indicated above. Seeds are grown in germination paper (12 inch ⁇ 18 inch pieces of Anchor Paper #SD7606), wetted in a solution of 0.5% KNO 3 and 0.1% Thyram. For each paper fifteen seeds are placed on the line evenly spaced such that the radicles will grow toward the same edge. The wet paper is rolled up evenly and tight enough to hold the seeds in place.
  • the roll is secured into place with two large paper clips, one at the top and one at the bottom.
  • the rolls are incubated in a growth chamber at 23 degrees C. for three days in a randomized complete block design within an appropriate container.
  • the chamber is set for 65% humidity with no light cycle.
  • For the cold stress treatment the rolls are then incubated in a growth chamber at 12 degrees C. for fourteen days.
  • the chamber is set for 65% humidity with no light cycle.
  • For the warm treatment the rolls are incubated at 23 degrees C. for an additional two days. After the treatment the germination papers are unrolled and the seeds that did not germinate are discarded. The lengths of the radicle and coleoptile for each seed are measured.
  • a coleoptile sample is collected from six individual kernels of each entry for confirming the expression of recombinant DNA. Statistical differences in the length of radicle and shoot during pre-shock and cold shock are used for an estimation of the effect of the cold treatment on corn plants. The analysis is conducted independently for the warm and cold treatments.
  • the first set is transgenic seeds with recombinant DNA, e.g., R2 inbred seeds or F1 hybrid seeds; the second seed set is non-transgenic, wild type negative control made from the same genotypes as the transgenic seeds. All seeds are treated with a fungicide as indicated above.
  • the seeds are planted in potting media in pots arranged in a randomized complete block design with 6 replications. Pots are watered as and when needed by filling water up to the brim of the pot. Plants are grown in a greenhouse to a V6 stage or approximately for 28 days. Greenhouse lights are turned on after emergence of seedlings with 14 hours of light 10 hours of dark.
  • Plants are fertilized twice each week with water-soluble fertilizer containing 200-ppm nitrogen.
  • water-soluble fertilizer containing 200-ppm nitrogen.
  • two pots are separated carefully to remove adhering sand by washing with water. Washed roots are cut at the first node. The roots are placed in a paper bag after squeezing excess water, folded once and stapled. The shoots are then folded up to a convenient size (approximately 15 cm), placed in a paper bag. Bags are placed over a wire shelve to facilitate drying in a ventilated room maintained at 120 degrees F. to a moisture content of about 13% then weighed to determine dried root and shoot biomass.
  • NIT Near Infrared Transmittance
  • the primary transformants are selfed to produce R1 seed which is planted to segregating seed. An untransformed control line is planted every sixth row. All plants are self-pollinated. A molecular assay is conducted to determine zygosity of the transgene in each plant. Ears are harvested at maturity, and well-filled ears are chosen for proximate analysis. Proximate analysis is conducted on up to 5 homozygous ears. If 5 good homozygous ears are not available, then hemizygous ears will be used to obtain 5 good transgene-positive ears. Statistical analysis is conducted to determine whether proximate values for transgenic events are different from controls.
  • Kernel composition is confirmed in an inbred confirmation nursery which is conducted with selected events, and is run with a design similar to that of the Gen2 nursery.
  • a “confirmed lead event” demonstrates an increase in oil with a p-value of less than or equal to 0.1 in two nurseries.
  • Grain samples from the multilocation hybrid yield trials are collected at the time of harvest and are analyzed by NIT. Controls are negative segregants, untransformed controls, or pollinators. Data from 3 to 12 locations are pooled for the statistical analysis. Putative leads have increased oil with a p-value of less than or equal to 0.1.
  • Transformation vectors were prepared to constitutively transcribe DNA in either sense orientation (for enhanced protein expression) or anti-sense orientation (for endogenous gene suppression) under the control of an enhanced Cauliflower Mosaic Virus 35S promoter (U.S. Pat. No. 5,359,142) directly or indirectly (Moore, et al., PNAS 95:376-381, 1998; Guyer, et al., Genetics 149: 633-639, 1998; International patent application NO. PCT/EP98/07577).
  • the transformation vectors also contain a bar gene as a selectable marker for resistance to glufosinate herbicide.
  • This example describes a soil drought tolerance screen to identify Arabidopsis plants transformed with recombinant DNA that wilt less rapidly and/or produce higher seed yield when grown in soil under drought conditions
  • T2 seeds were sown in flats filled with Metro/Mix® 200 (The Scotts® Company, USA).
  • Humidity domes were added to each flat and flats were assigned locations and placed in climate-controlled growth chambers. Plants were grown under a temperature regime of 22° C. at day and 20° C. at night, with a photoperiod of 16 hours and average light intensity of 170 ⁇ mol/m 2 /s. After the first true leaves appeared, humidity domes were removed. The plants were sprayed with glufosinate herbicide and put back in the growth chamber for 3 additional days. Flats were watered for 1 hour the week following the herbicide treatment. Watering was continued every seven days until the flower bud primordia became apparent, at which time plants were watered for the last time.
  • plants were evaluated for wilting response and seed yield. Beginning ten days after the last watering, plants were examined daily until 4 plants/line had wilted. In the next six days, plants were monitored for wilting response. Five drought scores were assigned according to the visual inspection of the phenotypes: 1 for healthy, 2 for dark green, 3 for wilting, 4 severe wilting, and 5 for dead. A score of 3 or higher was considered as wilted.
  • seed yield measured as seed weight per plant under the drought condition was characterized for the transgenic plants and their controls and analyzed as a quantitative response according to example 1M.
  • This example sets forth the heat stress tolerance screen to identify Arabidopsis plants transformed with the gene of interest that are more resistant to heat stress based on primarily their seedling weight and root growth under high temperature.
  • T2 seeds were plated on 1 ⁇ 2 ⁇ MS salts, 1% phytagel, with 10 ⁇ g/ml BASTA (7 per plate with 2 control seeds; 9 seeds total per plate). Plates were placed at 4° C. for 3 days to stratify seeds. Plates were then incubated at room temperature for 3 hours and then held vertically for 11 additional days at temperature of 34° C. at day and 20° C. at night. Photoperiod was 16 h. Average light intensity was ⁇ 140 ⁇ mol/m 2 /s. After 14 days of growth, plants were scored for glufosinate resistance, root length, final growth stage, visual color, and seedling fresh weight. A photograph of the whole plate was taken on day 14.
  • the seedling weight and root length were analyzed as quantitative responses according to example 1M.
  • the final grow stage at day 14 was scored as success if 50% of the plants had reached 3 rosette leaves and size of leaves are greater than 1 mm (Boyes, et al., (2001) The Plant Cell 13, 1499-1510).
  • the growth stage data was analyzed as a qualitative response according to example 1L.
  • Table 6 provides a list of recombinant DNA constructs that improve heat tolerance in transgenic plants.
  • This example sets forth the high salinity stress screen to identify Arabidopsis plants transformed with the gene of interest that are tolerant to high levels of salt based on their rate of development, root growth and chlorophyll accumulation under high salt conditions.
  • T2 seeds were plated on glufosinate selection plates containing 90 mM NaCl and grown under standard light and temperature conditions. All seedlings used in the experiment were grown at a temperature of 22° C. at day and 20° C. at night, a 16-hour photoperiod, an average light intensity of approximately 120 mmol/m 2 . On day 11, plants were measured for primary root length. After 3 more days of growth (day 14), plants were scored for transgenic status, primary root length, growth stage, visual color, and the seedlings were pooled for fresh weight measurement. A photograph of the whole plate was also taken on day 14.
  • the seedling weight and root length were analyzed as quantitative responses according to example 1M.
  • the final growth stage at day 14 was scored as success if 50% of the plants reached 3 rosette leaves and size of leaves are greater than 1 mm (Boyes, D. C., et al., (2001), The Plant Cell 13, 1499/1510).
  • the growth stage data was analyzed as a qualitative response according to example 1L.
  • Table 7 provides a list of recombinant DNA constructs that improve high salinity tolerance in transgenic plants TABLE 7 Seedling Root Length Root Length Weight Pep Growth Stage at day 11 at day 14 at day 14 SEQ RS p- p- p- p- ID Construct id Gene Orientation mean value c delta value c delta value c delta value c 512 19703 CGPG4172 SENSE 1.124 0.139 T 0.198 0.021 S 0.072 0.116 T 0.582 0.023 S 513 19946 CGPG4097 SENSE 1.201 0.072 T 0.02 0.89 / 0.069 0.573 / 0.443 0.266 / 514 19980 CGPG3914 SENSE 0.904 0.146 T 0.101 0.259 / 0.144 0.058 T 0.706 0.016 S 515 70435 CGPG3701 SENSE 1.363 0.031 S ⁇ 0.118 0.228 / 0.161 0.038 S 0.053 0.697 / 5
  • T2 seeds were plated on BASTA selection plates containing 3% PEG and grown under standard light and temperature conditions. Seeds were plated on each plate containing 3% PEG, 1 ⁇ 2 ⁇ MS salts, 1% phytagel, and 10 ⁇ g/ml glufosinate. Plates were placed at 4° C. for 3 days to stratify seeds. On day 11, plants were measured for primary root length. After 3 more days of growth, i.e., at day 14, plants were scored for transgenic status, primary root length, growth stage, visual color, and the seedlings were pooled for fresh weight measurement. A photograph of the whole plate was taken on day 14.
  • Seedling weight and root length were analyzed as quantitative responses according to example 1M.
  • the final growth stage at day 14 was scored as success or failure based on whether the plants reached 3 rosette leaves and size of leaves are greater than 1 mm.
  • the growth stage data was analyzed as a qualitative response according to example 1L.
  • Table 8 provides a list of recombinant DNA constructs that improve osmotic stress tolerance in transgenic plants.
  • This example set forth a screen to identify Arabidopsis plants transformed with the genes of interest that are more tolerant to cold stress subjected during day 8 to day 28 after seed planting. During these crucial early stages, seedling growth and leaf area increase were measured to assess tolerance when Arabidopsis seedlings were exposed to low temperatures. Using this screen, genetic alterations can be found that enable plants to germinate and grow better than wild type plants under sudden exposure to low temperatures.
  • Rosette areas were measured at day 8 and day 28, which were analyzed as quantitative responses according to example 1M.
  • Table 9 provides a list of recombinant nucleotides that improve cold shock stress tolerance in plants. TABLE 9 difference in rosette area rosette area rosette area between day 28 Pep at day 8 at day 28 and day 8 SEQ p- p- p- ID Construct_id Gene Orientation delta value c delta value c delta value c 270 14324 CGPG1560 SENSE 0.054 0.429 / 0.258 0.017 S ⁇ 0.071 0.631 / 271 17484 CGPG2630 SENSE ⁇ 0.189 0.759 / 0.544 0.025 S 0.275 0.121 T 272 19109 CGPG1381 ANTI- ⁇ 0.016 0.523 / 0.541 0.008 S 0.818 0.014 S SENSE 273 70423 CGPG3165 SENSE 0.316 0.012 S 0.521 0.022 S 0.89
  • This example sets forth a screen to identify Arabidopsis plants transformed with the genes of interests are resistant to cold stress based on their rate of development, root growth and chlorophyll accumulation under low temperature conditions.
  • T2 seeds were plated and all seedlings used in the experiment were grown at 8° C. Seeds were first surface disinfested using chlorine gas and then seeded on assay plates containing an aqueous solution of 1 ⁇ 2 ⁇ Gamborg's B/5 Basal Salt Mixture (Sigma/Aldrich Corp., St. Louis, Mo., USA G/5788), 1% PhytagelTM (Sigma-Aldrich, P-8169), and 10 ug/ml glufosinate with the final pH adjusted to 5.8 using KOH. Test plates were held vertically for 28 days at a constant temperature of 8° C., a photoperiod of 16 hr, and average light intensity of approximately 100 mmol/m 2 /s. At 28 days post planting, root length was measured, growth stage was observed, the visual color was assessed, and a whole plate photograph was taken.
  • 1 ⁇ 2 ⁇ Gamborg's B/5 Basal Salt Mixture Sigma/Aldrich Corp., St. Louis, Mo., USA G/
  • the root length at day 28 was analyzed as a quantitative response according to example 1M.
  • the growth stage at day 7 was analyzed as a qualitative response according to example 1L.
  • Table 10 provides a list of recombinant DNA constructs that improve cold stress tolerance in transgenic plants.
  • This protocol describes a screen to look for Arabidopsis plants that show an attenuated shade avoidance response and/or grow better than control plants under low light intensity. Of particular interest, we were looking for plants that didn't extend their petiole length, had an increase in seedling weight relative to the reference and had leaves that were more close to parallel with the plate surface.
  • T2 seeds were plated on glufosinate selection plates with 1 ⁇ 2 MS medium. Seeds were sown on 1 ⁇ 2 ⁇ MS salts, 1% Phytagel, 10 ug/ml BASTA. Plants were grown on vertical plates at a temperature of 22° C. at day, 20° C. at night and under low light (approximately 30 uE/m 2 /s, far/red ratio (655/665/725/735) ⁇ 0.35 using PLAQ lights with GAM color filter #680). Twenty-three days after seedlings were sown, measurements were recorded including seedling status, number of rosette leaves, status of flower bud, petiole leaf angle, petiole length, and pooled fresh weights. A digital image of the whole plate was taken on the measurement day. Seedling weight and petiole length were analyzed as quantitative responses according to example 1M. The number of rosette leaves, flowering bud formation and leaf angel were analyzed as qualitative responses according to example 1L.
  • Table 11 provides a list of recombinant DNA constructs that improve shade tolerance in plants TABLE 11 flowerbud Petiole Number of seedling formation Leaf Angle length rosette leaves weight Pep at day 23 at day 23 at day 23 at day 23 at day 23 at day 23 SEQ RS p- RS p- RS p- RS p- p- ID Construct_id Orientation mean value c mean value c mean value c delta value c 376 70426 SENSE 0.719 0.09 T 0.163 0.244 / ⁇ 0.206 0.185 T ⁇ 0.225 0.984 / 0.484 0.003 S 377 70772 SENSE ⁇ 0.501 0.858 / ⁇ 0.066 0.724 / ⁇ 0.692 0.004 S ⁇ 0.626 0.983 / ⁇ 0.693 0.023 / 378 71137 SENSE 0.26 0.384 / 0.11 0.168 T ⁇ 0.869 0.029 S 1.064 0.073 T ⁇ 0.453 0.288 /
  • This example sets forth a plate based phenotypic analysis platform for the rapid detection of phenotypes that are evident during the first two weeks of growth.
  • the transgenic plants with advantages in seedling growth and development were determined by the seedling weight and root length at day 14 after seed planting.
  • T2 seeds were plated on glufosinate selection plates and grown under standard conditions ( ⁇ 100 ⁇ E/m 2 /s, 16 h photoperiod, 22° C. at day, 20° C. at night). Seeds were stratified for 3 days at 4° C. Seedlings were grown vertically (at a temperature of 22° C. at day 20° C. at night). Observations were taken on day 10 and day 14. Both seedling weight and root length at day 14 were analyzed as quantitative responses according to example 1M.
  • Table 12 provides a list recombinant DNA constructs that improve early plant growth and development.
  • Pep Root Length Seedling Weight SEQ ID Construct_id gene Orientation delta p-value c delta p-value c 432 70217 CGPG6 SENSE 0.038 0.469 / 0.375 0.047 S 433 72711 CGPG1846 SENSE 0.132 0.021 S 0.601 0.001 S 434 70932 CGPG4089 SENSE 0.328 0.005 S 0.473 0.017 S 435 73518 CGPG6497 SENSE 0.287 0 S 0.634 0.036 S 436 19771 CGPG4011 SENSE 0.218 0.076 T 0.581 0.018 S 437 73549 CGPG6460 SENSE 0.139 0.003 S 0.349 0.03 S 438 72994 CGPG5803 SENSE 0.44 0.004 S 0.791 0.001 S 439 71928 CGPG1617 SENSE
  • This example sets forth a soil based phenotypic platform to identify genes that confer advantages in the processes of leaf development, flowering production and seed maturity to plants.
  • Arabidopsis plants were grown on a commercial potting mixture (Metro Mix 360, Scotts Co., Marysville, OH) consisting of 30-40% medium grade horticultural vermiculite, 35-55% sphagnum peat moss 10-20% processed bark ash, 1-15% pine bark and a starter nutrient charge. Soil was supplemented with Osmocote time-release fertilizer at a rate of 30 mg/ft 3 . T2 seeds were imbibed in 1% agarose solution for 3 days at 4° C. and then sown at a density of 5 per 21 ⁇ 2′′ pot. Thirty-two pots were ordered in a 4 by 8 grid in standard greenhouse flat.
  • Plants were grown in environmentally controlled rooms under a 16 h day length with an average light intensity of ⁇ 200 ⁇ moles/m 2 /s. Day and night temperature set points were 22° C. and 20° C., respectively. Humidity was maintained at 65%. Plants were watered by sub-irrigation every two days on average until mid-flowering, at which point the plants were watered daily until flowering was complete.
  • glufosinate was performed to select T2 individuals containing the target transgene. A single application of glufosinate was applied when the first true leaves were visible. Each pot was thinned to leave a single glufosinate-resistant seedling ⁇ 3 days after the selection was applied.
  • the rosette radius was measured at day 25.
  • the silique length was measured at day 40.
  • the plant parts were harvested at day 49 for dry weight measurements if flowering production was stopped. Otherwise, the dry weights of rosette and silique were carried out at day 53.
  • the seeds were harvested at day 58. All measurements were analyzed as quantitative responses according to example 1M.
  • Table 13 provides a list of recombinant DNA constructs that improve late plant growth and development.
  • TABLE 13 Rosette Dry Rosette Seed Dry Silique Dry Silique Pep Weight Radius Weight Weight Length SEQ p- p- p- p- p- ID Construct_id Orientation delta value c delta value c delta value c delta value c delta value c delta value c 480 14320 SENSE ⁇ 0.145 0.94 / 0.137 0.038 S ⁇ 0.702 1 / 0.477 0.002 S 0.016 0.276 / 481 16756 SENSE 0.485 0.016 S 0.223 0.025 S 0.148 0.042 S 0.481 0.002 S 0.147 0.013 S 482 17448 SENSE ⁇ 0.288 0.991 / ⁇ 0.054 0.829 / 0.376 0.008 S 0.185 0.034 S ⁇ 0.064 0.981 / 483 17633 SENSE 0.018 0.359 / 0.13 0.106 T
  • Arabidopsis seedlings become chlorotic and have less biomass.
  • This example sets forth the limited nitrogen tolerance screen to identify Arabidopsis plants transformed with the gene of interest that are altered in their ability to accumulate biomass and/or retain chlorophyll under low nitrogen condition.
  • T2 seeds were plated on glufosinate selection plates containing 0.5 ⁇ N-Free Hoagland's T 0.1 mM NH 4 NO 3 T 0.1% sucrose T 1% phytagel media and grown under standard light and temperature conditions. At 12 days of growth, plants were scored for seedling status (i.e., viable or non-viable) and root length. After 21 days of growth, plants were scored for visual color, seedling weight, number of green leaves, number of rosette leaves, root length and formation of flowering buds. A photograph of each plant was also taken at this time point.
  • the seedling weight and root length were analyzed as quantitative responses according to example 1M.
  • the number green leaves, the number of rosette leaves and the flowerbud formation were analyzed as qualitative responses according to example 1L.
  • Table 14 provides a list of recombinant DNA constructs that improve low nitrogen availability tolerance in plants.
  • Table 15 provides a list of responses that were analyzed as qualitative responses TABLE 15 response Screen categories (success vs. failure) wilting response Risk Soil drought tolerance screen non-wilted vs. wilted Score growth stage at day 14 heat stress tolerance screen 50% of plants reach stage1.03 vs. not growth stage at day 14 salt stress tolerance screen 50% of plants reach stage1.03 vs. not growth stage at day 14 PEG induced osmotic stress tolerance 50% of plants reach stage1.03 vs. not screen growth stage at day 7 cold germination tolerance screen 50% of plants reach stage 0.5 vs. not number of rosette leaves Shade tolerance screen 5 leaves appeared vs. not at day 23 flower bud formation at Shade tolerance screen flower buds appear vs.
  • Table 16 provides a list of responses that were analyzed as quantitative responses. TABLE 16 response screen seed yield Soil drought stress tolerance screen seedling weight at day 14 heat stress tolerance screen root length at day 14 heat stress tolerance screen seedling weight at day 14 salt stress tolerance screen root length at day 14 salt stress tolerance screen root length at day 11 salt stress tolerance screen seedling weight at day 14 PEG induced osmotic stress tolerance screen root length at day 11 PEG induced osmotic stress tolerance screen root length at day 14 PEG induced osmotic stress tolerance screen rosette area at day 8 cold shock tolerance screen rosette area at day28 cold shock tolerance screen difference in rosette area cold shock tolerance screen from day 8 to day 28 root length at day 28 cold germination tolerance screen seedling weight at day 23 Shade tolerance screen petiole length at day 23 Shade tolerance screen root length at day 14 Early plant growth and development screen Seedling weight at day 14 Early plant growth and development screen Rosette dry weight Late plant growth and development screen at day 53 rosette radius at day 25 Late plant growth and development screen seed dry weight at day 58 Late
  • the measurements (M) of each plant were transformed by log 2 calculation.
  • the Delta was calculated as log 2 M(transgenic)-log 2 M(reference).
  • the mean delta from multiple events of the transgene of interest was evaluated for statistical significance by t-test using S-PLUS statistical software (S-PLUS 6, Guide to statistics, Insightful, Seattle, Wash., USA).
  • S-PLUS 6 Guide to statistics, Insightful, Seattle, Wash., USA.
  • the Delta with a value greater than 0 indicates that the transgenic plants perform better than the reference.
  • the Delta with a value less than 0 indicates that the transgenic plants perform worse than the reference.
  • the Delta with a value equal to 0 indicates that the performance of the transgenic plants and the reference don't show any difference.
  • a BLAST searchable “All Protein Database” was constructed of known protein sequences using a proprietary sequence database and the National Center for Biotechnology Information (NCBI) non-redundant amino acid database (nr.aa). For each organism from which a DNA sequence provided herein was obtained, an “Organism Protein Database” was constructed of known protein sequences of the organism; the Organism Protein Database is a subset of the All Protein Database based on the NCBI taxonomy ID for the organism.
  • NCBI National Center for Biotechnology Information
  • the All Protein Database was queried using amino acid sequence of cognate protein for gene DNA used in trait-improving recombinant DNA, i.e., sequences of SEQ ID NO: 240 through SEQ ID NO: 478 using “blastp” with E-value cutoff of 1e-8. Up to 1000 top hits were kept, and separated by organism names. For each organism other than that of the query sequence, a list was kept for hits from the query organism itself with a more significant E-value than the best hit of the organism. The list contains likely duplicated genes, and is referred to as the Core List. Another list was kept for all the hits from each organism, sorted by E-value, and referred to as the Hit List.
  • the Organism Protein Database was queried using amino acid sequences of SEQ ID NO: 270 through SEQ ID NO: 538 using “blastp” with E-value cutoff of 1e-4. Up to 1000 top hits were kept. A BLAST searchable database was constructed based on these hits, and is referred to as “SubDB”. SubDB was queried with each sequence in the Hit List using “blastp” with E-value cutoff of 1e-8. The hit with the best E-value was compared with the Core List from the corresponding organism. The hit is deemed a likely ortholog if it belongs to the Core List, otherwise it is deemed not a likely ortholog and there is no further search of sequences in the Hit List for the same organism.
  • ClustalW program was selected for multiple sequence alignments of the amino acid sequence of SEQ ID NO: 379 and 10 homologs.
  • Three major factors affecting the sequence alignments dramatically are (1) protein weight matrices; (2) gap open penalty; (3) gap extension penalty.
  • Protein weight matrices available for ClustalW program include Blosum, Pam and Gonnet series. Those parameters with gap open penalty and gap extension penalty were extensively tested. On the basis of the test results, Blosum weight matrix, gap open penalty of 10 and gap extension penalty of 1 were chosen for multiple sequence alignment. Attached are the sequences of SEQ ID NO: 379, its homologs and the consensus sequence SEQ ID NO: 22569 at the end.
  • GATEWAYTM destination vectors (available from Invitrogen Life Technologies, Carlsbad, Calif.) are constructed for insertion of trait-improving DNA for corn transformation.
  • the elements of each destination vector are summarized in Table 18 below and include a selectable marker transcription region and a DNA insertion transcription region.
  • the selectable marker transcription region comprises a Cauliflower Mosaic Virus 35S promoter operably linked to a gene encoding neomycin phosphotransferase II (nptII) followed by both the 3′ region of the Agrobacterium tumefaciens nopaline synthase gene (nos) and the 3′ region of the potato proteinase inhibitor II (pinII) gene.
  • the DNA insertion transcription region comprises a rice actin 1 promoter, a rice actin 1 exon 1 intron1 enhancer, an att-flanked insertion site and the 3′ region of the potato pinII gene.
  • the att-flanked insertion region is replaced by recombination with trait-improving DNA, in a sense orientation for expression of a trait-improving protein and in a gene suppression orientation (i.e., either anti-sense orientation or in a sense- and anti-sense orientation) for a trait-improving suppression of a protein.
  • the vector with trait-improving DNA inserted at the att-flanked insertion region is useful for plant transformation by direct DNA delivery, such as microprojectile bombardment, it is preferable to bombard target plant tissue with tandem transcription units that have been cut from the vector.
  • the vector also comprises T-DNA borders from Agrobacterium flanking the transcription units.
  • Vectors for Agrobacterium -mediated transformation are prepared with each of the trait-improving genes having a sequence of SEQ ID NO:1 through SEQ ID NO:269 with the DNA solely in sense orientation for expression of the encoded, cognate trait-improving protein and in a gene suppression orientation for suppression of the cognate protein.
  • Each vector is transformed into corn callus which is propagated into a plant that is grown to produce transgenic seed for each transgenic event.
  • Progeny plants are self-pollinated to produce seed which is selected for homozygous seed. Homozygous seed is used for producing inbred plants, for introgressing the trait into elite lines, and for crossing to make hybrid seed.
  • the progeny transgenic plants comprising the trait-improving DNA with a sequence of SEQ ID NO: 1 through SEQ ID NO: 269 have one or more improved traits identified by agronomic trait screening including, but not limited to, enhanced nitrogen use efficiency, increased yield, enhanced water use efficiency, growth under cold stress and enhanced oil, starch and protein levels.
  • Transgenic corn including inbred and hybrids are also produced with DNA from each of the identified homologs of DNA of SEQ ID NO: 1 through SEQ ID NO: 269 to provide transgenic seeds and plants which are identified from total transgenic events by screening for the improved agronomic trait.
  • Transgenic corn plants are also produced where the trait-improving DNA is transcribed by each of the promoters from the group selected from, a maize globulin 1 promoter, a maize oleosin promoter, a glutelin 1 promoter, an aldolase promoter, a zein Z27 promoter, a pyruvate orthophosphate dikinase (PPDK) promoter, a soybean 7S alpha promoter, a peroxiredoxin antioxidant (Perl) promoter and a CaMV 35S promoter.
  • a maize globulin 1 promoter a maize oleosin promoter
  • glutelin 1 promoter an aldolase promoter
  • a zein Z27 promoter a pyruvate orthophosphate dikinase (PPDK) promoter
  • PPDK pyruvate orthophosphate dikinase
  • soybean 7S alpha promoter a peroxiredoxin antioxidant (Perl)
  • Seed produced by the plants is provided to growers to enable production of corn crops with improved traits associated with the trait-improving DNA.
  • TABLE 18 FUNCTION ELEMENT REFERENCE DNA insertion Rice actin 1 promoter U.S. Pat. No. 5,641,876 transcription region Rice actin 1 exon 1, intron 1 U.S. Pat. No.
  • Constructs for use in transformation of soybean are prepared by restriction enzyme based cloning into a common expression vector.
  • Elements of an exemplary common expression vector are shown in Table 19 below and include a selectable marker expression cassette and a gene of interest expression cassette.
  • the selectable marker expression cassette comprises Arabidopsis act 7 gene (AtAct7) promoter with intron and 5′UTR, the transit peptide of Arabidopsis EPSPS, the synthetic CP4 coding region with dicot preferred codon usage and a 3′ UTR of the nopaline synthase gene.
  • the gene of interest expression cassette comprises a Cauliflower Mosaic Virus 35S promoter operably linked to a trait-improving gene in a sense orientation for expression of a trait-improving protein and in a gene suppression orientation (i.e., either anti-sense orientation or in a sense- and anti-sense orientation for a trait-improving suppression of a protein.
  • Vectors similar to that described above are constructed for use in Agrobacterium mediated soybean transformation systems, with each of the trait-improving DNA having a sequence of SEQ ID NO:1 though SEQ ID NO:269 and the respective identified homologs with the DNA in sense orientation for expression of the encoded, cognate protein and in a gene suppression arrangement for suppression of the cognate protein.
  • Each vector is transformed into soybean embryo tissue to produce transgenic events which are grown into plants that produce progeny transgenic plants and seed for screening to identify the transgenic soybean plants of this invention that exhibit the enhanced agronomic trait imparted by DNA with a sequence of SEQ ID NO:1 through SEQ ID NO:269 or a respective homolog.
  • transgenic soybean plants of this invention are identified by agronomic trait screening including, but not limited to, enhanced nitrogen use efficiency, increased yield, enhanced water use efficiency, growth under cold stress and enhanced oil, starch and protein levels.
  • Transgenic soybean plants are also produced where the trait-improving DNA is transcribed by a napin promoter and Arabidopsis SSU promoter.
  • Seed produced by the plants is provided to growers to enable production of soybean crops with improved traits associated with the trait-improving DNA.
  • TABLE 19 Function Element Reference Agro transformation B-ARGtu.right border Depicker, A. et al (1982) Mol Appl Genet 1: 561-573 Antibiotic resistance CR-Ec.aadA-SPC/STR Repressor of primers from the ColE1 plasmid CR-Ec.rop Origin of replication OR-Ec.oriV-RK2 Agro transformation B-ARGtu.left border Barker, R. F.
  • Vectors similar to that described above for soybean transformation are constructed for use in Agrobacterium mediated cotton transformation systems, with each of the trait-improving DNA having a sequence of SEQ ID NO:1 though SEQ ID NO:269 and the respective identified homologs with the DNA in sense orientation for expression of the encoded, cognate protein and in a gene suppression arrangement for suppression of the cognate protein.
  • Each vector is transformed into cotton embryo tissue to produce transgenic events which are grown into plants that produce progeny transgenic plants and seed for screening to identify the transgenic soybean plants of this invention that exhibit the enhanced agronomic trait imparted by DNA with a sequence of SEQ ID NO:1 through SEQ ID NO:269 or a respective homolog.
  • transgenic cotton plants of this invention are identified by agronomic trait screening including, but not limited to, enhanced nitrogen use efficiency, increased yield, enhanced water use efficiency, growth under cold stress and enhanced oil, starch and protein levels.
  • Transgenic cotton plants are also produced where the trait-improving DNA is transcribed by a napin promoter and Arabidopsis SSU promoter.
  • Seed produced by the plants is provided to growers to enable production of cotton crops with improved traits associated with the trait-improving DNA.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Botany (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
US11/188,298 2004-07-31 2005-07-22 Genes and uses for plant improvement Abandoned US20060075522A1 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
US11/188,298 US20060075522A1 (en) 2004-07-31 2005-07-22 Genes and uses for plant improvement
US11/982,700 US9115368B2 (en) 2004-07-31 2007-11-01 Genes and uses for plant improvement
US14/121,854 US20150135367A1 (en) 2004-07-31 2014-10-24 Genes and uses for plant improvement
US15/731,003 US10301643B2 (en) 2004-07-31 2017-04-06 Genes and uses for plant improvement

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US59297804P 2004-07-31 2004-07-31
US11/188,298 US20060075522A1 (en) 2004-07-31 2005-07-22 Genes and uses for plant improvement

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US11/982,700 Division US9115368B2 (en) 2004-07-31 2007-11-01 Genes and uses for plant improvement

Publications (1)

Publication Number Publication Date
US20060075522A1 true US20060075522A1 (en) 2006-04-06

Family

ID=35207765

Family Applications (4)

Application Number Title Priority Date Filing Date
US11/188,298 Abandoned US20060075522A1 (en) 2004-07-31 2005-07-22 Genes and uses for plant improvement
US11/982,700 Active US9115368B2 (en) 2004-07-31 2007-11-01 Genes and uses for plant improvement
US14/121,854 Abandoned US20150135367A1 (en) 2004-07-31 2014-10-24 Genes and uses for plant improvement
US15/731,003 Active 2025-08-06 US10301643B2 (en) 2004-07-31 2017-04-06 Genes and uses for plant improvement

Family Applications After (3)

Application Number Title Priority Date Filing Date
US11/982,700 Active US9115368B2 (en) 2004-07-31 2007-11-01 Genes and uses for plant improvement
US14/121,854 Abandoned US20150135367A1 (en) 2004-07-31 2014-10-24 Genes and uses for plant improvement
US15/731,003 Active 2025-08-06 US10301643B2 (en) 2004-07-31 2017-04-06 Genes and uses for plant improvement

Country Status (2)

Country Link
US (4) US20060075522A1 (fr)
EP (2) EP2295582A3 (fr)

Cited By (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040045049A1 (en) * 1998-09-22 2004-03-04 James Zhang Polynucleotides and polypeptides in plants
WO2008011681A1 (fr) * 2006-07-27 2008-01-31 Adelaide Research And Innovation Pty Ltd Polysaccharide transférase
US20080090998A1 (en) * 2004-07-31 2008-04-17 Abad Mark S Genes and uses for plant improvement
WO2008073617A2 (fr) * 2006-11-03 2008-06-19 Ceres, Inc. Augmentation de la tolerance de vegetaux a des conditions de faible luminosite
US20080254524A1 (en) * 2007-04-16 2008-10-16 Charles Abbas Increased Ethanol Production from Xylose
US20090011480A1 (en) * 2007-06-01 2009-01-08 Solazyme, Inc. Use of Cellulosic Materials for Cultivation of Microorganisms
WO2009003216A1 (fr) * 2007-06-29 2009-01-08 Agriculture Victoria Services Pty Ltd Modification du métabolisme des flavonoïdes dans des végétaux
WO2008049098A3 (fr) * 2006-10-19 2009-04-09 Merck & Co Inc Antagonistes d'anticorps du récepteur α1 de l'interleukine-13
US20090307800A1 (en) * 2008-06-10 2009-12-10 Pioneer Hi-Bred International, Inc. Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase
US20100011470A1 (en) * 2008-06-13 2010-01-14 Performance Plants,Inc. Methods and means of increasing the water use efficiency of plants
WO2010021798A1 (fr) * 2008-08-21 2010-02-25 University Of Florida Research Foundation, Inc. Amélioration de la tolérance au stress des cultures, du rendement et de la qualité par le biais d'une surexpression de la glutarédoxine
WO2010036951A2 (fr) * 2008-03-03 2010-04-01 Joule Biotechnologies, Inc. Procédés et compositions pour produire des produits d’intérêt à base de carbone dans des micro-organismes
US20110177228A1 (en) * 2008-08-13 2011-07-21 Ceres, Inc. Plant nucelotide sequences and corresponding polypeptides
WO2012154626A1 (fr) * 2011-05-06 2012-11-15 Solazyme, Inc. Microorganismes génétiquement modifiés qui métabolisent le xylose
US8481030B2 (en) 2010-03-01 2013-07-09 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
WO2013133454A1 (fr) * 2012-03-08 2013-09-12 株式会社カネカ Plante résistante au stress environnemental avec productivité des semences élevée et son procédé d'élaboration
US8592188B2 (en) 2010-05-28 2013-11-26 Solazyme, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
EP2631241A3 (fr) * 2006-10-10 2014-04-09 The Australian National University Procédé pour la formation d'une protéine et utilisations de celle-ci
US8697427B2 (en) 2008-11-28 2014-04-15 Solazyme, Inc. Recombinant microalgae cells producing novel oils
US8846375B2 (en) 2012-04-18 2014-09-30 Solazyme, Inc. Tailored oils
US8852885B2 (en) 2011-02-02 2014-10-07 Solazyme, Inc. Production of hydroxylated fatty acids in Prototheca moriformis
US8945889B2 (en) 2012-05-11 2015-02-03 Danisco Us Inc. Method of using alpha-amylase from Aspergillus clavatus for saccharification
US9066527B2 (en) 2010-11-03 2015-06-30 Solazyme, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US9101100B1 (en) 2014-04-30 2015-08-11 Ceres, Inc. Methods and materials for high throughput testing of transgene combinations
AU2009319313B2 (en) * 2008-11-26 2015-08-20 BASF Agricultural Solutions Seed US LLC Expression cassettes for seed-specific expression in plants
US20150232901A1 (en) * 2012-08-16 2015-08-20 Danisco Us Inc. Method of using alpha-amylase from aspergillus clavatus and isoamylase for saccharification
US9200039B2 (en) 2013-03-15 2015-12-01 Symic Ip, Llc Extracellular matrix-binding synthetic peptidoglycans
US9217016B2 (en) 2011-05-24 2015-12-22 Symic Ip, Llc Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
US9434956B2 (en) 2008-08-29 2016-09-06 Los Alamos National Security, Llc Transgenic plants with enhanced growth characteristics
US9512192B2 (en) 2008-03-27 2016-12-06 Purdue Research Foundation Collagen-binding synthetic peptidoglycans, preparation, and methods of use
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
CN107805633A (zh) * 2016-09-06 2018-03-16 中国科学院微生物研究所 OsMPK4蛋白及编码基因在调控植物种子发育中的应用
WO2018075624A1 (fr) * 2016-10-18 2018-04-26 The Regents Of The University Of California Rhéostat moléculaire pour l'équilibre de cofacteur
US9969990B2 (en) 2014-07-10 2018-05-15 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
US10053715B2 (en) 2013-10-04 2018-08-21 Corbion Biotech, Inc. Tailored oils
CN108586595A (zh) * 2018-05-17 2018-09-28 中国农业科学院作物科学研究所 水稻mis2基因及其编码蛋白与应用
US10119127B2 (en) 2008-08-29 2018-11-06 Los Alamos National Security, Llc Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof
US10138499B2 (en) 2009-12-23 2018-11-27 Danisco Us Inc. Methods for improving the efficiency of simultaneous saccharification and fermentation reactions
US10190108B2 (en) 2011-03-17 2019-01-29 Danisco Us Inc. Method for reducing viscosity in saccharification process
US10248758B2 (en) * 2013-02-07 2019-04-02 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
US10273465B2 (en) 2009-09-23 2019-04-30 Danisco Us Inc. Glycosyl hydrolase enzymes and uses thereof
US10287604B2 (en) * 2008-03-14 2019-05-14 Toyota Jidosha Kabushiki Kaisha Gene for increasing the production of plant biomass and/or seeds and method for use thereof
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
WO2021030423A1 (fr) * 2019-08-13 2021-02-18 The Feinstein Institutes For Medical Research Anticorps monoclonaux ciblant la tétranectine pour lutter contre la septicémie létale et d'autres pathologies
WO2021088352A1 (fr) * 2019-11-08 2021-05-14 江南大学 Procédé de production de génistéine glycosylée à longue chaîne
US11203743B2 (en) 2019-11-08 2021-12-21 Jiangnan University Method for producing long-chain glycosylated genistein
CN114958866A (zh) * 2022-05-09 2022-08-30 中国科学院遗传与发育生物学研究所 调控大豆分枝数的基因及其用途
WO2022250697A1 (fr) * 2021-05-28 2022-12-01 Cargill, Incorporated Procédé de fermentation pour la production d'acide malonique
US11529424B2 (en) 2017-07-07 2022-12-20 Symic Holdings, Inc. Synthetic bioconjugates
CN116217683A (zh) * 2022-09-08 2023-06-06 深圳全棉时代科技有限公司 一种与棉花纤维品质相关的基因、超表达载体和敲除载体及应用
WO2023081910A3 (fr) * 2021-11-08 2023-06-15 Cornell University Complexes d'enzymes rubisco modifiées
CN116284291A (zh) * 2022-12-23 2023-06-23 东北农业大学 OsCNX1蛋白及其编码基因在调控水稻种子萌发中的应用
CN117025627A (zh) * 2023-06-29 2023-11-10 中国烟草总公司郑州烟草研究院 烟草氯离子通道蛋白NtCLC13及其编码基因和应用
US12123008B2 (en) 2019-11-08 2024-10-22 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006089950A2 (fr) * 2005-02-26 2006-08-31 Basf Plant Science Gmbh Cassettes d'expression destinees a une expression preferentielle de semences chez des plantes
CA2699066A1 (fr) 2007-09-14 2009-03-19 Basf Plant Science Gmbh Vegetaux ayant un rendement ameliore associe aux traits et une methode de fabrication desdits vegetaux renfermant l'expression d'un facteur d'un polypeptide a facteur de regulation de croissance
EP2594647A3 (fr) * 2007-09-21 2013-07-24 BASF Plant Science GmbH Plantes ayant un rendement amélioré
WO2010108122A1 (fr) * 2009-03-20 2010-09-23 Sanford-Burnham Medical Research Institute Administration ciblee d'agents chimiotherapeutiques
US9562081B2 (en) 2009-05-04 2017-02-07 Carnegie Institution Of Washington Sugar transporters
CA2780179A1 (fr) 2009-11-06 2011-05-12 Novozymes, Inc. Compositions pour la saccharification des matieres cellulosiques
US8741298B2 (en) 2011-02-07 2014-06-03 Neotope Biosciences Limited APOE immunotherapy
MX2013009749A (es) * 2011-02-28 2013-10-01 Basf Plant Science Co Gmbh Plantas que tienen rasgos relacionados con rendimiento mejorado y metodos para producir los mismos.
EP2697252B1 (fr) * 2011-04-11 2016-08-10 Cargill, Incorporated Compositions et procédés pour une production accrue d'éthanol à partir de biomasse
WO2012143865A1 (fr) * 2011-04-22 2012-10-26 Basf Plant Science Company Gmbh Plantes présentant des caractères liés au rendement améliorés et procédé pour les produire
US20140349320A1 (en) * 2011-12-15 2014-11-27 The Trustees Of The University Of Pennsylvania Using Adaptive Immunity to Detect Drug Resistance
BR112015018618B1 (pt) 2013-02-05 2022-08-30 University Of Saskatchewan Composição e métodos para melhorar a vitalidade de sementes, a saúde e/ou o rendimento de uma planta
US10136646B2 (en) 2013-06-26 2018-11-27 Indigo Ag, Inc. Agricultural endophyte-plant compositions, and methods of use
NZ715728A (en) 2013-06-26 2017-04-28 Indigo Ag Inc Seed-origin endophyte populations, compositions, and methods of use
CA2921784C (fr) * 2013-08-21 2023-03-07 Commonwealth Scientific And Industrial Research Organisation Gene de resistance a la rouille lr67 qui donne a une plante une resistance contre un pathogene fongique biotrophe
CA2916060A1 (fr) * 2013-08-27 2015-03-05 Evogene Ltd. Polynucleotides et polypeptides isoles, et procedes les utilisant pour augmenter un rendement vegetal et/ou des caracteristiques agricoles
EP3041338B1 (fr) 2013-09-04 2019-12-11 Indigo AG, Inc. Compositions agricoles associant plantes et endophytes et leurs procédés de préparation
CN110506636A (zh) 2013-11-06 2019-11-29 德克萨斯A&M大学体系 用于提高作物产量和防虫害的真菌内生菌
WO2015100432A2 (fr) 2013-12-24 2015-07-02 Symbiota, Inc. Procédé de propagation de micro-organismes dans des bioréacteurs végétaux et de stockage stable de micro-organismes dans des graines agricoles
CA2935218C (fr) 2013-12-24 2021-01-26 Indigo Ag, Inc. Plantes contenant des endophytes benefiques
US9364005B2 (en) 2014-06-26 2016-06-14 Ait Austrian Institute Of Technology Gmbh Plant-endophyte combinations and uses therefor
US11525143B2 (en) 2014-02-28 2022-12-13 Universidade Federal Do Rio De Janeiro Method for promoting an increase in plant biomass, productivity, and drought resistance
BR102014004881A2 (pt) 2014-02-28 2016-02-02 Univ Rio De Janeiro método para promover um aumento da biomassa e produtividade vegetal e da tolerância à seca
WO2015135078A1 (fr) * 2014-03-12 2015-09-17 The Governing Council Of The University Of Toronto Plantes ayant une résistance améliorée aux agents pathogènes et procédés de modulation de la résistance de plantes aux agents pathogènes
AU2015278238B2 (en) 2014-06-20 2018-04-26 The Flinders University Of South Australia Inoculants and methods for use thereof
EP3161124B1 (fr) 2014-06-26 2020-06-03 Indigo Ag, Inc. Endophytes, compositions associées et leurs méthodes d'utilisation
US10266862B2 (en) * 2014-11-06 2019-04-23 Industry-Academic Cooperation Foundation Gyeongsang National University Method for preparing psicose
WO2016089931A1 (fr) * 2014-12-03 2016-06-09 Monsanto Technology Llc Plantes transgéniques présentant des caractéristiques améliorées
WO2016108750A1 (fr) * 2014-12-29 2016-07-07 Swetree Technologies Ab Plantes ligneuses à caractéristiques de croissance améliorées
US10570407B2 (en) 2014-12-29 2020-02-25 Swetree Technologies Ab Woody plants having improved growth properties
CA2972904C (fr) 2014-12-30 2023-11-14 Indigo Agriculture, Inc. Endophytes de graines presents parmi des cultivars et des especes, compositions associees, et leurs procedes d'utilisation
CN104604554B (zh) * 2015-01-13 2017-02-01 江苏省农业科学院 一种耐盐甜高粱种质鉴定的方法
WO2016130087A1 (fr) * 2015-02-11 2016-08-18 Temasek Life Sciences Laboratory Limited Régulation du temps de floraison de la plante
MX2017013864A (es) 2015-05-01 2018-04-24 Indigo Agriculture Inc Composiciones endofitas en complejo aisladas y metodos para mejorar los rasgos de plantas.
AU2016258913B2 (en) 2015-05-01 2019-11-07 Indigo Ag, Inc. Designed complex endophyte compositions and methods for improved plant traits
WO2016200987A1 (fr) 2015-06-08 2016-12-15 Indigo Agriculture, Inc. Compositions d'endophyte de genre streptomyces et procédés pour l4amélioration de caractéristiques agronomiques dans les plantes
BR112018012839A2 (pt) 2015-12-21 2018-12-04 Indigo Ag Inc composições endofíticas e métodos para melhoramento de traços de plantas em plantas de importância agronômica
BR112018012980A2 (pt) * 2016-01-15 2018-12-04 British American Tobacco Investments Ltd método para modificar brotação lateral em uma planta, método para produzir uma planta que tem brotação lateral reduzida e/ou atrasada, célula, planta, material de propagação de planta, folha colhida de uma planta, folha processada, produto de tabaco, uso, uso de uma planta, planta ou semente e uso da planta
CN105567702B (zh) * 2016-02-06 2018-08-17 浙江省萧山棉麻研究所 红掌SOC转录因子AaSOC及其编码基因与应用
AU2017366699A1 (en) 2016-12-01 2019-07-18 Indigo Ag, Inc. Modulated nutritional quality traits in seeds
MX2019007637A (es) 2016-12-23 2019-12-16 Texas A & M Univ Sys Endófitos fúngicos para mejores rendimientos de los cultivos y protección contra las plagas.
US10645938B2 (en) 2017-03-01 2020-05-12 Indigo Ag, Inc. Endophyte compositions and the methods for improvement of plant traits
EP3589128A1 (fr) 2017-03-01 2020-01-08 Indigo AG, Inc. Compositions d'endophyte et procédés d'amélioration de caractéristiques de plante
EP3629742A4 (fr) 2017-04-27 2022-01-05 Flinders University Of South Australia Inoculants bactériens
CA3066470A1 (fr) * 2017-06-23 2018-12-27 Yield10 Bioscience, Inc. Procedes et genes pour produire des plantes terrestres avec une expression accrue de genes de transporteur de metabolite mitochondrial et/ou de transporteur de dicarboxylate plastidial
US11263707B2 (en) 2017-08-08 2022-03-01 Indigo Ag, Inc. Machine learning in agricultural planting, growing, and harvesting contexts
EP3684167A2 (fr) 2017-09-18 2020-07-29 Indigo AG, Inc. Marqueurs de santé végétale
EP3684175A1 (fr) 2017-09-22 2020-07-29 Technische Universität Graz Particules polymères contenant des micro-organismes
CN110028563A (zh) * 2018-01-11 2019-07-19 中国科学院植物研究所 蛋白质OsMADS27在调控植物种子的萌发时间和调控植物种子的休眠中的应用
WO2019203942A1 (fr) * 2018-04-18 2019-10-24 Pioneer Hi-Bred International, Inc. Procédés d'identification, de sélection et de production de riz résistant à la brûlure helminthosporienne bactérienne
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN110317816B (zh) * 2019-07-12 2022-03-08 云南省烟草农业科学研究院 一种能提高烟草抗旱的转录因子NtMYB44b及其定点突变方法与应用
CN111286508B (zh) * 2019-08-29 2022-04-22 南京林业大学 银杏类黄酮3′,5′-羟化酶GbF3′5′H1基因及其蛋白和应用
CN111876431B (zh) * 2020-07-28 2022-03-15 武汉大学 水稻OsSDY1基因、生物材料、方法、表达载体转化宿主及其在抗逆稳产上的应用
WO2023225459A2 (fr) 2022-05-14 2023-11-23 Novozymes A/S Compositions et procédés de prévention, de traitement, de suppression et/ou d'élimination d'infestations et d'infections phytopathogènes
WO2022192241A2 (fr) 2021-03-08 2022-09-15 Greenlight Biosciences, Inc. Lutte contre l'oïdium de la vigne à base d'arn
WO2023216046A1 (fr) * 2022-05-09 2023-11-16 中国科学院遗传与发育生物学研究所 Gène pour réguler et contrôler le nombre de branches de soja, et son utilisation
CN118272423A (zh) * 2024-03-28 2024-07-02 福建省农业科学院水稻研究所 转录因子OsbZIP05在水稻种子活力负向调控中的应用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030233675A1 (en) * 2002-02-21 2003-12-18 Yongwei Cao Expression of microbial proteins in plants for production of plants with improved properties

Family Cites Families (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5034322A (en) 1983-01-17 1991-07-23 Monsanto Company Chimeric genes suitable for expression in plant cells
US5352605A (en) 1983-01-17 1994-10-04 Monsanto Company Chimeric genes for transforming plant cells using viral promoters
DE3587548T2 (de) 1984-12-28 1993-12-23 Bayer Ag Rekombinante DNA, die in pflanzliche Zellen eingebracht werden kann.
US5420034A (en) 1986-07-31 1995-05-30 Calgene, Inc. Seed-specific transcriptional regulation
CA1313830C (fr) 1985-08-07 1993-02-23 Dilip Maganlal Shah Plantes resistant au glyphosate
CA1293460C (fr) 1985-10-07 1991-12-24 Brian Lee Sauer Recombinaison a des sites specifiques de l'adn dans les levures
US5107065A (en) 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5453566A (en) 1986-03-28 1995-09-26 Calgene, Inc. Antisense regulation of gene expression in plant/cells
US5004863B2 (en) 1986-12-03 2000-10-17 Agracetus Genetic engineering of cotton plants and lines
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5359142A (en) 1987-01-13 1994-10-25 Monsanto Company Method for enhanced expression of a protein
US5322938A (en) 1987-01-13 1994-06-21 Monsanto Company DNA sequence for enhancing the efficiency of transcription
US5250515A (en) 1988-04-11 1993-10-05 Monsanto Company Method for improving the efficacy of insect toxins
US5416011A (en) 1988-07-22 1995-05-16 Monsanto Company Method for soybean transformation and regeneration
BR9007159A (pt) 1989-02-24 1991-12-10 Monsanto Co Genes sinteticos de plantas e processo para a preparacao dos mesmos
US5231020A (en) 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
ES2150900T3 (es) 1989-10-31 2000-12-16 Monsanto Co Promotor para plantas transgenicas.
HUT57265A (en) 1989-11-03 1991-11-28 Zaadunie Bv Process for producing plants of diminished infection-sensitivity
US5641876A (en) 1990-01-05 1997-06-24 Cornell Research Foundation, Inc. Rice actin gene and promoter
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
WO1991010725A1 (fr) 1990-01-22 1991-07-25 Dekalb Plant Genetics Plantes de mais transgeniques fertiles
US6025545A (en) * 1990-01-22 2000-02-15 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5837848A (en) 1990-03-16 1998-11-17 Zeneca Limited Root-specific promoter
AU655197B2 (en) 1990-06-25 1994-12-08 Monsanto Technology Llc Glyphosate tolerant plants
US5633435A (en) 1990-08-31 1997-05-27 Monsanto Company Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
CA2139319A1 (fr) 1992-07-02 1994-01-20 Sudhir Agrawal Oligonucleotides autostabilisees utilises comme agents therapeutiques
EP0604662B1 (fr) 1992-07-07 2008-06-18 Japan Tobacco Inc. Procede de transformation d'une monocotyledone
EP0578627A1 (fr) 1992-07-09 1994-01-12 Monsanto Company Plantes résistantes aux virus
US5527695A (en) 1993-01-29 1996-06-18 Purdue Research Foundation Controlled modification of eukaryotic genomes
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
US5631152A (en) 1994-10-26 1997-05-20 Monsanto Company Rapid and efficient regeneration of transgenic plants
GB9422571D0 (en) * 1994-11-09 1995-01-04 Whitehall Lab Ltd Haemorrihoidal compositions and method of use
DE69634875T2 (de) 1995-12-27 2006-04-27 Japan Tobacco Inc. Kälteindusierbare promotorsequenzen
DE19631919C2 (de) 1996-08-07 1998-07-16 Deutsches Krebsforsch Anti-Sinn-RNA mit Sekundärstruktur
US6140078A (en) 1996-09-05 2000-10-31 Unilever Patent Holdings Salt-inducible promoter derivable from a lactic acid bacterium, and its use in a lactic acid bacterium for production of a desired protein
WO1998031822A1 (fr) 1997-01-20 1998-07-23 Plant Genetic Systems, N.V. Promoteurs de plantes provoques par des pathogenes
US5922564A (en) 1997-02-24 1999-07-13 Performance Plants, Inc. Phosphate-deficiency inducible promoter
US6376754B1 (en) 1997-03-07 2002-04-23 Asgrow Seed Company Plants having resistance to multiple herbicides and its use
GB9710475D0 (en) 1997-05-21 1997-07-16 Zeneca Ltd Gene silencing
US6162965A (en) * 1997-06-02 2000-12-19 Novartis Ag Plant transformation methods
CA2311632A1 (fr) 1997-11-26 1999-06-03 Sandra Lynn Volrath Procede et compositions activant les transgenes silencieux
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
ES2273127T3 (es) 1998-02-26 2007-05-01 Pioneer Hi-Bred International, Inc. Promotor alfa-tubulin 3-18 del maiz.
WO1999043819A1 (fr) 1998-02-26 1999-09-02 Pioneer Hi-Bred International, Inc. Famille de genes pr-1 et de promoteurs
US6107549A (en) 1998-03-10 2000-08-22 Monsanto Company Genetically engineered plant resistance to thiazopyr and other pyridine herbicides
JP4187413B2 (ja) 1998-03-20 2008-11-26 コモンウェルス サイエンティフィック アンドインダストリアル リサーチ オーガナイゼーション 遺伝子発現の制御
US5914451A (en) 1998-04-06 1999-06-22 Monsanto Company Efficiency soybean transformation protocol
PT1068311E (pt) 1998-04-08 2011-07-20 Commw Scient Ind Res Org Processos e meios de obter fenótipos modificados
US6635806B1 (en) 1998-05-14 2003-10-21 Dekalb Genetics Corporation Methods and compositions for expression of transgenes in plants
US6307123B1 (en) 1998-05-18 2001-10-23 Dekalb Genetics Corporation Methods and compositions for transgene identification
AUPP370498A0 (en) 1998-05-25 1998-06-18 Nalco Chemical Company Dextran, starch and flocculant combination for improving red mud clarification
JP2000083680A (ja) 1998-07-16 2000-03-28 Nippon Paper Industries Co Ltd 光誘導型プロモ―タ―の制御下に置かれた不定芽再分化遺伝子を選抜マ―カ―遺伝子とする植物への遺伝子導入方法及びこれに用いる植物への遺伝子導入用ベクタ―
US6506599B1 (en) 1999-10-15 2003-01-14 Tai-Wook Yoon Method for culturing langerhans islets and islet autotransplantation islet regeneration
US6448476B1 (en) 1998-11-17 2002-09-10 Monsanto Technology Llc Plants and plant cells transformation to express an AMPA-N-acetyltransferase
WO2000042207A2 (fr) 1999-01-14 2000-07-20 Monsanto Technology Llc Procede de transformation de soja
FR2788660A1 (fr) * 1999-01-27 2000-07-28 Centre Nat Rech Scient UTILISATION DE PLANTES TRANSGENIQUES SUREXPRIMANT LE GENE enod 40
CA2300692A1 (fr) 1999-02-25 2000-08-25 Ceres, Incorporated Fragments d'adn obtenus par sequencage et polypeptides codes correspondants obtenus a partir de ces produits
EP1586645A3 (fr) 1999-02-25 2006-02-22 Ceres Incorporated Fragments d'ADN avec des séquences déterminées et polypeptides encodées par lesdits fragments
EP1033405A3 (fr) * 1999-02-25 2001-08-01 Ceres Incorporated Fragments d'ADN avec des séquences déterminées et polypeptides encodées par lesdits fragments
US20090265815A1 (en) * 2000-08-09 2009-10-22 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded therapy
WO2000052183A1 (fr) 1999-03-05 2000-09-08 Monsanto Technology Llc Vecteurs d'expression multigeniques destines a la biosynthese de produits au moyen de mecanismes biologiques multienzymes
US20100293669A2 (en) * 1999-05-06 2010-11-18 Jingdong Liu Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
US6207879B1 (en) 1999-05-14 2001-03-27 Dekalb Genetics Corporation Maize RS81 promoter and methods for use thereof
US6429357B1 (en) 1999-05-14 2002-08-06 Dekalb Genetics Corp. Rice actin 2 promoter and intron and methods for use thereof
US6194636B1 (en) 1999-05-14 2001-02-27 Dekalb Genetics Corp. Maize RS324 promoter and methods for use thereof
US6232526B1 (en) 1999-05-14 2001-05-15 Dekalb Genetics Corp. Maize A3 promoter and methods for use thereof
US20020192813A1 (en) 1999-08-18 2002-12-19 Timothy W. Conner Plant expression vectors
US6326193B1 (en) 1999-11-05 2001-12-04 Cambria Biosciences, Llc Insect control agent
WO2002000904A2 (fr) 2000-06-23 2002-01-03 E. I. Du Pont De Nemours And Company Constructions recombinees et leur utilisation pour reduire l'expression de genes
US20020048814A1 (en) 2000-08-15 2002-04-25 Dna Plant Technology Corporation Methods of gene silencing using poly-dT sequences
US7109393B2 (en) 2000-08-15 2006-09-19 Mendel Biotechnology, Inc. Methods of gene silencing using inverted repeat sequences
AU8681101A (en) * 2000-08-24 2002-03-04 Scripps Research Inst Stress-regulated genes of plants, transgenic plants containing same, and methodsof use
BRPI0116305B1 (pt) * 2000-12-21 2016-01-12 Monsanto Technology Llc moléculas de dna associadas com proliferação e desenvolvimento de células de plantas e métodos de produzir plantas com tamanho de órgão aumentado.
US7151204B2 (en) 2001-01-09 2006-12-19 Monsanto Technology Llc Maize chloroplast aldolase promoter compositions and methods for use thereof
US20030150017A1 (en) 2001-11-07 2003-08-07 Mesa Jose Ramon Botella Method for facilitating pathogen resistance
EP2294915A3 (fr) 2002-03-21 2011-04-13 Monsanto Technology LLC Constructions d'acides nucléotiques et procédés de productions de compositions d'huile de graines modifiées
AR039717A1 (es) 2002-06-21 2005-03-09 Monsanto Technology Llc Construcciones de arn de intrones cadena doble y usos de las mismas
US20040123347A1 (en) 2002-12-20 2004-06-24 Hinchey Brendan S. Water-deficit-inducible plant promoters
US9777287B2 (en) 2003-08-18 2017-10-03 Ceres, Inc. Nucleotide sequences and corresponding polypeptides conferring modified phenotype characteristics in plants
US10428344B2 (en) * 2003-08-18 2019-10-01 Ceres, Inc. Nucleotide sequences and corresponding polypeptides conferring modified phenotype characteristics in plants
US20060107345A1 (en) * 2003-09-30 2006-05-18 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060150283A1 (en) 2004-02-13 2006-07-06 Nickolai Alexandrov Sequence-determined DNA fragments and corresponding polypeptides encoded thereby
US20060075522A1 (en) 2004-07-31 2006-04-06 Jaclyn Cleveland Genes and uses for plant improvement
JP4324220B2 (ja) 2006-03-06 2009-09-02 パナソニック株式会社 フォトマスク、その作成方法、そのフォトマスクを用いたパターン形成方法及びマスクデータ作成方法
US20090026581A1 (en) * 2007-07-25 2009-01-29 Jin-Ha Park Flash memory device and method of manufacturing the same

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030233675A1 (en) * 2002-02-21 2003-12-18 Yongwei Cao Expression of microbial proteins in plants for production of plants with improved properties

Cited By (133)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070061911A9 (en) * 1998-09-22 2007-03-15 James Zhang Polynucleotides and polypeptides in plants
US7345217B2 (en) 1998-09-22 2008-03-18 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
US20040045049A1 (en) * 1998-09-22 2004-03-04 James Zhang Polynucleotides and polypeptides in plants
US9115368B2 (en) 2004-07-31 2015-08-25 Monsanto Technology Llc Genes and uses for plant improvement
US20080090998A1 (en) * 2004-07-31 2008-04-17 Abad Mark S Genes and uses for plant improvement
US10301643B2 (en) 2004-07-31 2019-05-28 Monsanto Technology Llc Genes and uses for plant improvement
WO2008011681A1 (fr) * 2006-07-27 2008-01-31 Adelaide Research And Innovation Pty Ltd Polysaccharide transférase
US20100009414A1 (en) * 2006-07-27 2010-01-14 Adelaide Research And Innovation Pty Ltd Polysaccharide transferase
EP2631241A3 (fr) * 2006-10-10 2014-04-09 The Australian National University Procédé pour la formation d'une protéine et utilisations de celle-ci
US9598688B2 (en) 2006-10-10 2017-03-21 The Australian National University Process for generation of protein and uses therof
US10041058B2 (en) 2006-10-10 2018-08-07 The Australian National University Process for generation of protein and uses thereof
US8207304B2 (en) 2006-10-19 2012-06-26 Csl Limited Antibody antagonists of interleukin-13 receptor α1
WO2008049098A3 (fr) * 2006-10-19 2009-04-09 Merck & Co Inc Antagonistes d'anticorps du récepteur α1 de l'interleukine-13
US20090285799A1 (en) * 2006-10-19 2009-11-19 Andrew Donald Nash Antibody Antagonists of Interleukin-13 Receptor Alpha1
WO2008073617A2 (fr) * 2006-11-03 2008-06-19 Ceres, Inc. Augmentation de la tolerance de vegetaux a des conditions de faible luminosite
WO2008073617A3 (fr) * 2006-11-03 2008-09-18 Ceres Inc Augmentation de la tolerance de vegetaux a des conditions de faible luminosite
US20100205688A1 (en) * 2006-11-03 2010-08-12 Shing Kwok Increasing tolerance of plants to low light conditions
WO2008130603A3 (fr) * 2007-04-16 2009-12-23 Archer-Daniels-Midland Company Production d'éthanol améliorée à partir de xylose
WO2008130603A2 (fr) * 2007-04-16 2008-10-30 Archer-Daniels-Midland Company Production d'éthanol améliorée à partir de xylose
US20080254524A1 (en) * 2007-04-16 2008-10-16 Charles Abbas Increased Ethanol Production from Xylose
US8071298B2 (en) 2007-04-16 2011-12-06 Archer Daniels Midland Company Increased ethanol production from xylose
US8790914B2 (en) 2007-06-01 2014-07-29 Solazyme, Inc. Use of cellulosic materials for cultivation of microorganisms
US8476059B2 (en) 2007-06-01 2013-07-02 Solazyme, Inc. Sucrose feedstock utilization for oil-based fuel manufacturing
US20110014665A1 (en) * 2007-06-01 2011-01-20 Solazyme, Inc. Production of Oil in Microorganisms
US9434909B2 (en) 2007-06-01 2016-09-06 Solazyme, Inc. Renewable diesel and jet fuel from microbial sources
US20090011480A1 (en) * 2007-06-01 2009-01-08 Solazyme, Inc. Use of Cellulosic Materials for Cultivation of Microorganisms
US20090035842A1 (en) * 2007-06-01 2009-02-05 Solazyme, Inc. Sucrose Feedstock Utilization for Oil-Based Fuel Manufacturing
US8889401B2 (en) 2007-06-01 2014-11-18 Solazyme, Inc. Production of oil in microorganisms
US8889402B2 (en) 2007-06-01 2014-11-18 Solazyme, Inc. Chlorella species containing exogenous genes
US10138435B2 (en) 2007-06-01 2018-11-27 Corbion Biotech, Inc. Renewable diesel and jet fuel from microbial sources
US8497116B2 (en) 2007-06-01 2013-07-30 Solazyme, Inc. Heterotrophic microalgae expressing invertase
US8633355B2 (en) 2007-06-29 2014-01-21 Agriculture Victoria Services Pty Ltd Modification of plant flavonoid metabolism
WO2009003216A1 (fr) * 2007-06-29 2009-01-08 Agriculture Victoria Services Pty Ltd Modification du métabolisme des flavonoïdes dans des végétaux
AU2008271901B2 (en) * 2007-06-29 2015-01-22 Agriculture Victoria Services Pty Ltd Modification of plant flavonoid metabolism
US20100186114A1 (en) * 2007-06-29 2010-07-22 Agriculture Victoria Services Pty Ltd. Modification of Plant Flavonoid Metabolism
WO2010036951A3 (fr) * 2008-03-03 2010-06-24 Joule Unlimited, Inc. Procédés et compositions pour produire des produits d’intérêt à base de carbone dans des micro-organismes
WO2010036951A2 (fr) * 2008-03-03 2010-04-01 Joule Biotechnologies, Inc. Procédés et compositions pour produire des produits d’intérêt à base de carbone dans des micro-organismes
US10287604B2 (en) * 2008-03-14 2019-05-14 Toyota Jidosha Kabushiki Kaisha Gene for increasing the production of plant biomass and/or seeds and method for use thereof
US10689425B2 (en) 2008-03-27 2020-06-23 Purdue Research Foundation Collagen-binding synthetic peptidoglycans, preparation, and methods of use
US9512192B2 (en) 2008-03-27 2016-12-06 Purdue Research Foundation Collagen-binding synthetic peptidoglycans, preparation, and methods of use
US20130133111A1 (en) * 2008-06-10 2013-05-23 Pioneer Hi-Bred International, Inc. Compositions and methods of use of mitogen-activated protein kinase kinase kinase
US20090307800A1 (en) * 2008-06-10 2009-12-10 Pioneer Hi-Bred International, Inc. Compositions and Methods of Use of Mitogen-Activated Protein Kinase Kinase Kinase
US8362225B2 (en) 2008-06-10 2013-01-29 Pioneer Hi-Bred International, Inc. Compositions and methods of use of mitogen-activated protein kinase kinase kinase
US11453889B2 (en) 2008-06-13 2022-09-27 Performance Plants, Inc. Vector comprising sorghum terminator and method of use
US20100011470A1 (en) * 2008-06-13 2010-01-14 Performance Plants,Inc. Methods and means of increasing the water use efficiency of plants
US10508283B2 (en) 2008-06-13 2019-12-17 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants
US11913008B2 (en) 2008-06-13 2024-02-27 Performance Plants, Inc. Vector comprising sorghum terminator and method of use
US11827895B2 (en) 2008-06-13 2023-11-28 Performance Plants, Inc. Vector comprising sorghum promotor and method of use
US11220696B2 (en) 2008-06-13 2022-01-11 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants
US9453238B2 (en) * 2008-06-13 2016-09-27 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants
US10036035B2 (en) 2008-06-13 2018-07-31 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants
US8344211B2 (en) * 2008-08-13 2013-01-01 Ceres, Inc. Plant nucleotide sequences and corresponding polypeptides
US20110177228A1 (en) * 2008-08-13 2011-07-21 Ceres, Inc. Plant nucelotide sequences and corresponding polypeptides
WO2010021798A1 (fr) * 2008-08-21 2010-02-25 University Of Florida Research Foundation, Inc. Amélioration de la tolérance au stress des cultures, du rendement et de la qualité par le biais d'une surexpression de la glutarédoxine
US8519226B2 (en) 2008-08-21 2013-08-27 University Of Florida Research Foundation, Inc. Increased stress tolerance, yield, and quality via glutaredoxin overexpression
US20110131681A1 (en) * 2008-08-21 2011-06-02 Bala Rathinasabapathi Increased Stress Tolerance, Yield, and Quality via Glutaredoxin Overexpression
US10119127B2 (en) 2008-08-29 2018-11-06 Los Alamos National Security, Llc Nucleic acids encoding plant glutamine phenylpyruvate transaminase (GPT) and uses thereof
US9434956B2 (en) 2008-08-29 2016-09-06 Los Alamos National Security, Llc Transgenic plants with enhanced growth characteristics
US9862964B2 (en) 2008-08-29 2018-01-09 Los Alamos National Security, Llc Transgenic plants with enhanced growth characteristics
AU2009319313B2 (en) * 2008-11-26 2015-08-20 BASF Agricultural Solutions Seed US LLC Expression cassettes for seed-specific expression in plants
US9593351B2 (en) 2008-11-28 2017-03-14 Terravia Holdings, Inc. Recombinant microalgae including sucrose invertase and thioesterase
US10260076B2 (en) 2008-11-28 2019-04-16 Corbion Biotech, Inc. Heterotrophically cultivated recombinant microalgae
US8697427B2 (en) 2008-11-28 2014-04-15 Solazyme, Inc. Recombinant microalgae cells producing novel oils
US9353389B2 (en) 2008-11-28 2016-05-31 Solazyme, Inc. Nucleic acids useful in the manufacture of oil
US9464304B2 (en) 2008-11-28 2016-10-11 Terravia Holdings, Inc. Methods for producing a triglyceride composition from algae
US9062294B2 (en) 2008-11-28 2015-06-23 Solazyme, Inc. Renewable fuels produced from oleaginous microorganisms
US8951777B2 (en) 2008-11-28 2015-02-10 Solazyme, Inc. Recombinant microalgae cells producing novel oils
US10273465B2 (en) 2009-09-23 2019-04-30 Danisco Us Inc. Glycosyl hydrolase enzymes and uses thereof
US10138499B2 (en) 2009-12-23 2018-11-27 Danisco Us Inc. Methods for improving the efficiency of simultaneous saccharification and fermentation reactions
USRE47150E1 (en) 2010-03-01 2018-12-04 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US8481030B2 (en) 2010-03-01 2013-07-09 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US9309324B2 (en) 2010-03-01 2016-04-12 Bayer Healthcare Llc Optimized monoclonal antibodies against tissue factor pathway inhibitor (TFPI)
US9657299B2 (en) 2010-05-28 2017-05-23 Terravia Holdings, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
US8592188B2 (en) 2010-05-28 2013-11-26 Solazyme, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
US9279136B2 (en) 2010-05-28 2016-03-08 Solazyme, Inc. Methods of producing triacylglyceride compositions comprising tailored oils
US9255282B2 (en) 2010-05-28 2016-02-09 Solazyme, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
US8765424B2 (en) 2010-05-28 2014-07-01 Solazyme, Inc. Tailored oils produced from recombinant heterotrophic microorganisms
US10006034B2 (en) 2010-05-28 2018-06-26 Corbion Biotech, Inc. Recombinant microalgae including keto-acyl ACP synthase
US9109239B2 (en) 2010-05-28 2015-08-18 Solazyme, Inc. Hydroxylated triacylglycerides
US9388435B2 (en) 2010-11-03 2016-07-12 Terravia Holdings, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US10344305B2 (en) 2010-11-03 2019-07-09 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US10167489B2 (en) 2010-11-03 2019-01-01 Corbion Biotech, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US9066527B2 (en) 2010-11-03 2015-06-30 Solazyme, Inc. Microbial oils with lowered pour points, dielectric fluids produced therefrom, and related methods
US9249436B2 (en) 2011-02-02 2016-02-02 Solazyme, Inc. Tailored oils produced from recombinant oleaginous microorganisms
US10100341B2 (en) 2011-02-02 2018-10-16 Corbion Biotech, Inc. Tailored oils produced from recombinant oleaginous microorganisms
US8852885B2 (en) 2011-02-02 2014-10-07 Solazyme, Inc. Production of hydroxylated fatty acids in Prototheca moriformis
US10190108B2 (en) 2011-03-17 2019-01-29 Danisco Us Inc. Method for reducing viscosity in saccharification process
US8846352B2 (en) 2011-05-06 2014-09-30 Solazyme, Inc. Genetically engineered microorganisms that metabolize xylose
US9499845B2 (en) 2011-05-06 2016-11-22 Terravia Holdings, Inc. Genetically engineered microorganisms that metabolize xylose
WO2012154626A1 (fr) * 2011-05-06 2012-11-15 Solazyme, Inc. Microorganismes génétiquement modifiés qui métabolisent le xylose
US9217016B2 (en) 2011-05-24 2015-12-22 Symic Ip, Llc Hyaluronic acid-binding synthetic peptidoglycans, preparation, and methods of use
CN104349665A (zh) * 2012-03-08 2015-02-11 株式会社钟化 具有高种子生产力的环境应激抗性植物及生成该植物的方法
US20150211016A1 (en) * 2012-03-08 2015-07-30 Kaneka Corporation Environmental stress-resistant plant with high seed productivity and method for producing the same
WO2013133454A1 (fr) * 2012-03-08 2013-09-12 株式会社カネカ Plante résistante au stress environnemental avec productivité des semences élevée et son procédé d'élaboration
US10683522B2 (en) 2012-04-18 2020-06-16 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US9551017B2 (en) 2012-04-18 2017-01-24 Terravia Holdings, Inc. Structuring fats and methods of producing structuring fats
US9102973B2 (en) 2012-04-18 2015-08-11 Solazyme, Inc. Tailored oils
US8945908B2 (en) 2012-04-18 2015-02-03 Solazyme, Inc. Tailored oils
US9068213B2 (en) 2012-04-18 2015-06-30 Solazyme, Inc. Microorganisms expressing ketoacyl-CoA synthase and uses thereof
US8846375B2 (en) 2012-04-18 2014-09-30 Solazyme, Inc. Tailored oils
US11401538B2 (en) 2012-04-18 2022-08-02 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US9200307B2 (en) 2012-04-18 2015-12-01 Solazyme, Inc. Tailored oils
US9909155B2 (en) 2012-04-18 2018-03-06 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US9249441B2 (en) 2012-04-18 2016-02-02 Solazyme, Inc. Tailored oils
US10287613B2 (en) 2012-04-18 2019-05-14 Corbion Biotech, Inc. Structuring fats and methods of producing structuring fats
US9719114B2 (en) 2012-04-18 2017-08-01 Terravia Holdings, Inc. Tailored oils
US8945889B2 (en) 2012-05-11 2015-02-03 Danisco Us Inc. Method of using alpha-amylase from Aspergillus clavatus for saccharification
US9365871B2 (en) * 2012-05-11 2016-06-14 Danisco Us Inc. Method of using α-amylase from Aspergillus clavatus for saccharification
US20150152442A1 (en) * 2012-05-11 2015-06-04 Danisco Us Inc. Method of using alpha-amylase from aspergillus clavatus for saccharification
US20150232901A1 (en) * 2012-08-16 2015-08-20 Danisco Us Inc. Method of using alpha-amylase from aspergillus clavatus and isoamylase for saccharification
US10248758B2 (en) * 2013-02-07 2019-04-02 University Of Washington Through Its Center For Commercialization Self-assembling protein nanostructures
US9872887B2 (en) 2013-03-15 2018-01-23 Purdue Research Foundation Extracellular matrix-binding synthetic peptidoglycans
US9200039B2 (en) 2013-03-15 2015-12-01 Symic Ip, Llc Extracellular matrix-binding synthetic peptidoglycans
US10053715B2 (en) 2013-10-04 2018-08-21 Corbion Biotech, Inc. Tailored oils
US10772931B2 (en) 2014-04-25 2020-09-15 Purdue Research Foundation Collagen binding synthetic peptidoglycans for treatment of endothelial dysfunction
US9101100B1 (en) 2014-04-30 2015-08-11 Ceres, Inc. Methods and materials for high throughput testing of transgene combinations
US9969990B2 (en) 2014-07-10 2018-05-15 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
US10316299B2 (en) 2014-07-10 2019-06-11 Corbion Biotech, Inc. Ketoacyl ACP synthase genes and uses thereof
CN107805633A (zh) * 2016-09-06 2018-03-16 中国科学院微生物研究所 OsMPK4蛋白及编码基因在调控植物种子发育中的应用
WO2018075624A1 (fr) * 2016-10-18 2018-04-26 The Regents Of The University Of California Rhéostat moléculaire pour l'équilibre de cofacteur
US10760103B2 (en) 2016-10-18 2020-09-01 The Regents Of The University Of California Molecular rheostat for cofactor balance
US11529424B2 (en) 2017-07-07 2022-12-20 Symic Holdings, Inc. Synthetic bioconjugates
CN108586595A (zh) * 2018-05-17 2018-09-28 中国农业科学院作物科学研究所 水稻mis2基因及其编码蛋白与应用
WO2021030423A1 (fr) * 2019-08-13 2021-02-18 The Feinstein Institutes For Medical Research Anticorps monoclonaux ciblant la tétranectine pour lutter contre la septicémie létale et d'autres pathologies
WO2021088352A1 (fr) * 2019-11-08 2021-05-14 江南大学 Procédé de production de génistéine glycosylée à longue chaîne
US11203743B2 (en) 2019-11-08 2021-12-21 Jiangnan University Method for producing long-chain glycosylated genistein
US12123008B2 (en) 2019-11-08 2024-10-22 Performance Plants, Inc. Methods and means of increasing the water use efficiency of plants
WO2022250697A1 (fr) * 2021-05-28 2022-12-01 Cargill, Incorporated Procédé de fermentation pour la production d'acide malonique
WO2023081910A3 (fr) * 2021-11-08 2023-06-15 Cornell University Complexes d'enzymes rubisco modifiées
CN114958866A (zh) * 2022-05-09 2022-08-30 中国科学院遗传与发育生物学研究所 调控大豆分枝数的基因及其用途
CN116217683A (zh) * 2022-09-08 2023-06-06 深圳全棉时代科技有限公司 一种与棉花纤维品质相关的基因、超表达载体和敲除载体及应用
CN116284291A (zh) * 2022-12-23 2023-06-23 东北农业大学 OsCNX1蛋白及其编码基因在调控水稻种子萌发中的应用
CN117025627A (zh) * 2023-06-29 2023-11-10 中国烟草总公司郑州烟草研究院 烟草氯离子通道蛋白NtCLC13及其编码基因和应用

Also Published As

Publication number Publication date
EP2295582A2 (fr) 2011-03-16
EP2295582A8 (fr) 2011-08-03
EP1621632A1 (fr) 2006-02-01
EP2295582A3 (fr) 2011-11-16
US20170292131A1 (en) 2017-10-12
US9115368B2 (en) 2015-08-25
US20150135367A1 (en) 2015-05-14
US10301643B2 (en) 2019-05-28
US20080090998A1 (en) 2008-04-17

Similar Documents

Publication Publication Date Title
US10301643B2 (en) Genes and uses for plant improvement
US10538781B2 (en) Mate family genes and uses for plant improvement
US20220251593A1 (en) Genes and uses for plant enhancement
US10301642B2 (en) Genes and uses for plant enhancement
US20190032073A1 (en) Genes and uses for plant improvement
EP2292773B1 (fr) Gènes et utilisation pour l'amélioration de plantes
AU2006204997B2 (en) Genes and uses for plant improvement
EP2271760A2 (fr) Gènes et leurs utilisations pour améliorer les plantes
WO2008153927A2 (fr) Gènes et leurs utilisations pour l'amélioration des plantes
AU2011253798B2 (en) Genes and uses for plant improvement
EP1818404A2 (fr) Gènes et utilisation pour l'amélioration de plantes

Legal Events

Date Code Title Description
AS Assignment

Owner name: MONSANTO TECHNOLOGY LLC, MISSOURI

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MCDONALD, MARIA;KARUNANANDAA, BALASULOJINI;SAYED, MAHMOOD;AND OTHERS;REEL/FRAME:016993/0723;SIGNING DATES FROM 20051005 TO 20051202

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION